0001290658 2026-01-01 2026-03-31 0001290658 2026-07-09 0001290658 2026-03-31 0001290658 2025-12-31 0001290658 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001290658 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesCPreferredStockMember 2026-03-31 0001290658 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesDPreferredStockMember 2026-03-31 0001290658 us-gaap:SeriesDPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001290658 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001290658 us-gaap:SeriesEPreferredStockMember 2026-03-31 0001290658 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001290658 2025-01-01 2025-03-31 0001290658 ITOX:PreferredStockSeriesAMember 2025-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2025-12-31 0001290658 us-gaap:CommonStockMember 2025-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001290658 us-gaap:RetainedEarningsMember 2025-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2024-12-31 0001290658 ITOX:PreferredStockSeriesEMember 2024-12-31 0001290658 us-gaap:CommonStockMember 2024-12-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001290658 us-gaap:RetainedEarningsMember 2024-12-31 0001290658 2024-12-31 0001290658 ITOX:PreferredStockSeriesAMember 2026-01-01 2026-03-31 0001290658 ITOX:PreferredStockSeriesEMember 2026-01-01 2026-03-31 0001290658 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001290658 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001290658 ITOX:PreferredStockSeriesAMember 2025-01-01 2025-03-31 0001290658 ITOX:PreferredStockSeriesEMember 2025-01-01 2025-03-31 0001290658 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001290658 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001290658 ITOX:PreferredStockSeriesAMember 2026-03-31 0001290658 ITOX:PreferredStockSeriesEMember 2026-03-31 0001290658 us-gaap:CommonStockMember 2026-03-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001290658 us-gaap:RetainedEarningsMember 2026-03-31 0001290658 ITOX:PreferredStockSeriesAMember 2025-03-31 0001290658 ITOX:PreferredStockSeriesEMember 2025-03-31 0001290658 us-gaap:CommonStockMember 2025-03-31 0001290658 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001290658 us-gaap:RetainedEarningsMember 2025-03-31 0001290658 2025-03-31 0001290658 ITOX:StockIncentivePlan2017Member 2026-01-01 2026-03-31 0001290658 ITOX:StockIncentivePlan2019Member 2026-01-01 2026-03-31 0001290658 ITOX:StockIncentivePlan2017Member 2025-12-31 0001290658 ITOX:StockIncentivePlan2017Member 2024-12-31 0001290658 ITOX:StockIncentivePlan2019Member 2024-12-31 0001290658 ITOX:StockIncentivePlan2019Member 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2022-03-18 0001290658 ITOX:StockIncentivePlan2022Member 2026-01-01 2026-03-31 0001290658 ITOX:StockIncentivePlan2022Member 2025-01-01 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2024-01-01 2024-12-31 0001290658 ITOX:EmmonsMember us-gaap:SeriesEPreferredStockMember ITOX:ConsultingAgreementMember 2025-10-29 2025-10-30 0001290658 srt:ChiefExecutiveOfficerMember 2026-01-01 2026-03-31 0001290658 srt:ChiefExecutiveOfficerMember 2026-03-31 0001290658 srt:ChiefExecutiveOfficerMember 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2026-03-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2025-12-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2026-01-01 2026-03-31 0001290658 ITOX:ConvertibleNotesPayableGMember 2025-01-01 2025-03-31 0001290658 us-gaap:ConvertibleNotesPayableMember 2026-01-01 2026-03-31 0001290658 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-03-31 0001290658 ITOX:VestedSharesToDirectorsAndOfficersMember 2026-01-01 2026-03-31 0001290658 ITOX:VestedSharesToDirectorsAndOfficersMember 2025-01-01 2025-03-31 0001290658 ITOX:UnvestedSharesToDirectorsAndOfficersMember 2026-01-01 2026-03-31 0001290658 ITOX:UnvestedSharesToDirectorsAndOfficersMember 2025-01-01 2025-03-31 0001290658 ITOX:ConvertiblePromissoryNoteMember ITOX:OfficerAndDirectorMember 2023-12-31 0001290658 ITOX:ConvertiblePromissoryNoteMember ITOX:NoteholderMember 2024-02-04 2024-02-05 0001290658 ITOX:ConvertiblePromissoryNoteMember ITOX:NoteholderMember ITOX:SeriesCConvertiblePreferredStockMember 2024-02-04 2024-02-05 0001290658 ITOX:ConvertiblePromissoryNoteMember 2026-03-31 0001290658 ITOX:ConvertiblePromissoryNoteMember 2025-12-31 0001290658 srt:ChiefExecutiveOfficerMember ITOX:ConsultingAgreementMember 2026-01-01 2026-03-31 0001290658 srt:ChiefExecutiveOfficerMember ITOX:ConsultingAgreementMember 2026-03-31 0001290658 srt:ChiefExecutiveOfficerMember ITOX:ConsultingAgreementMember 2025-12-31 0001290658 ITOX:EmmonsDEAMember ITOX:AccruedCompensationAndUnpaidFeesMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsDEAMember us-gaap:SeriesEPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsDEAMember us-gaap:SeriesAPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:EmmonsMember 2026-03-31 0001290658 ITOX:EmmonsMember 2025-12-31 0001290658 ITOX:StockIncentivePlan2017Member 2025-10-30 0001290658 ITOX:StockIncentivePlan2017Member 2026-03-31 0001290658 ITOX:StockIncentivePlan2019Member 2019-03-11 0001290658 ITOX:StockIncentivePlan2019Member 2025-10-30 0001290658 ITOX:StockIncentivePlan2019Member 2026-03-31 0001290658 ITOX:StockIncentivePlan2022Member 2022-03-19 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2026-03-24 0001290658 ITOX:StockIncentivePlan2022Member 2025-10-30 0001290658 ITOX:StockIncentivePlan2022Member 2026-03-31 0001290658 us-gaap:SeriesAPreferredStockMember 2025-10-30 0001290658 ITOX:SeriesASupervotingPreferredStockMember 2025-11-05 0001290658 us-gaap:SeriesBPreferredStockMember 2020-11-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2020-11-18 2020-11-19 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2020-11-19 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2020Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2020-12-15 2020-12-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2020-12-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2020Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2021-12-19 2021-12-20 0001290658 ITOX:SecuritiesPurchaseAgreementMember us-gaap:SeriesAPreferredStockMember ITOX:IssuedDecember2021Member 2021-12-19 2021-12-20 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedDecember2021Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2022-02-06 2022-02-07 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2022-02-07 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedFebruary2022Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2022-03-23 2022-03-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2022-03-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedMarch2022Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2022-11-16 2022-11-17 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2022-11-17 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedNovember2022Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2023-08-23 2023-08-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2023-08-24 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2024-04-15 2024-04-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2024-04-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedAugust2023Member 2024-04-15 2024-04-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2024-04-16 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedApril2024Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2024-10-02 2024-10-03 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2024-10-03 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesBConvertiblePreferredStockMember ITOX:IssuedOctober2024Member 2025-12-31 0001290658 us-gaap:SeriesCPreferredStockMember 2024-01-08 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2024-02-27 2024-03-01 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2024-03-01 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2026-01-01 2026-03-31 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2025-01-01 2025-03-31 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2026-03-31 0001290658 ITOX:NoteBMember ITOX:SeriesCConvertiblePreferredStockMember ITOX:IssuedMarch2024Member 2025-12-31 0001290658 ITOX:SeriesDConvertiblePreferredStockMember 2025-03-17 0001290658 us-gaap:SeriesDPreferredStockMember 2025-03-17 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-03-20 2025-03-21 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-03-21 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-01-01 2025-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch2025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-04-09 2025-04-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-04-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedApril2025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-05-13 2025-05-14 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-05-09 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay2025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-05-13 2025-05-14 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-05-09 2025-05-10 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMay142025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-10-29 2025-10-30 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-10-30 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedOctober302025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-12-01 2025-12-02 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-12-02 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedDecember22025Member 2025-12-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch122026Member 2026-03-11 2026-03-12 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch122026Member 2026-03-12 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch122026Member 2026-01-01 2026-03-31 0001290658 ITOX:SecuritiesPurchaseAgreementMember ITOX:SeriesDConvertiblePreferredStockMember ITOX:IssuedMarch122026Member 2026-03-31 0001290658 us-gaap:SeriesEPreferredStockMember 2025-10-30 0001290658 ITOX:EmmonsDEAMember 2026-01-01 2026-03-31 0001290658 ITOX:EmmonsDEAMember 2026-03-31 0001290658 ITOX:EmmonsDEAMember 2025-12-31 0001290658 ITOX:MittaDEAMember ITOX:MittaPromissoryNotePayableMember 2025-10-29 2025-10-30 0001290658 ITOX:MittaDEAMember us-gaap:SeriesEPreferredStockMember ITOX:MittaPromissoryNotePayableMember 2025-10-29 2025-10-30 0001290658 ITOX:MittaDEAMember us-gaap:SeriesAPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:MittaDEAMember 2026-01-01 2026-03-31 0001290658 ITOX:MittaDEAMember 2026-03-31 0001290658 ITOX:MittaDEAMember 2025-12-31 0001290658 ITOX:McnemarDEAMember ITOX:AccruedAndUnpaidFeesMember 2025-10-29 2025-10-30 0001290658 ITOX:McnemarDEAMember us-gaap:SeriesEPreferredStockMember ITOX:AccruedAndUnpaidFeesMember 2025-10-29 2025-10-30 0001290658 ITOX:McnemarDEAMember us-gaap:SeriesAPreferredStockMember 2025-10-29 2025-10-30 0001290658 ITOX:McnemarDEAMember 2026-01-01 2026-03-31 0001290658 ITOX:McnemarDEAMember 2026-03-31 0001290658 ITOX:McnemarDEAMember 2025-12-31 0001290658 ITOX:SeniorSecuredDEAMember ITOX:GoginSeniorSecuredNotesMember 2025-10-29 2025-10-30 0001290658 ITOX:SeniorSecuredDEAMember us-gaap:SeriesEPreferredStockMember ITOX:GoginSeniorSecuredNotesMember 2025-10-29 2025-10-30 0001290658 ITOX:SeniorSecuredDEAMember 2026-01-01 2026-03-31 0001290658 ITOX:SeniorSecuredDEAMember 2026-03-31 0001290658 ITOX:SeniorSecuredDEAMember 2025-12-31 0001290658 ITOX:SeriesBConvertiblePreferredStockMember 2026-03-31 0001290658 ITOX:SeriesBConvertiblePreferredStockMember 2025-12-31 0001290658 ITOX:SeriesCConvertiblePreferredStockMember 2026-03-31 0001290658 ITOX:SeriesCConvertiblePreferredStockMember 2025-12-31 0001290658 ITOX:SeriesDConvertiblePreferredStockMember 2026-03-31 0001290658 ITOX:SeriesDConvertiblePreferredStockMember 2025-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2024-12-31 0001290658 ITOX:StockIncentivePlan2022Member 2025-01-01 2025-03-31 0001290658 ITOX:StockIncentivePlan2022Member 2025-03-31 0001290658 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2024-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2025-01-01 2025-03-31 0001290658 us-gaap:FairValueInputsLevel2Member 2025-01-01 2025-03-31 0001290658 us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-03-31 0001290658 us-gaap:FairValueInputsLevel1Member 2025-03-31 0001290658 us-gaap:FairValueInputsLevel2Member 2025-03-31 0001290658 us-gaap:FairValueInputsLevel3Member 2025-03-31 0001290658 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001290658 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001290658 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001290658 us-gaap:FairValueInputsLevel1Member 2026-01-01 2026-03-31 0001290658 us-gaap:FairValueInputsLevel2Member 2026-01-01 2026-03-31 0001290658 us-gaap:FairValueInputsLevel3Member 2026-01-01 2026-03-31 0001290658 us-gaap:FairValueInputsLevel1Member 2026-03-31 0001290658 us-gaap:FairValueInputsLevel2Member 2026-03-31 0001290658 us-gaap:FairValueInputsLevel3Member 2026-03-31 iso4217:USD shares iso4217:USD shares ITOX:Integer false 2026 Q1 --12-31 0001290658

10-Q true 2026-03-31 false 000-50773 IIOT-OXYS, INC. NV 56-2415252 705 Cambridge Street Cambridge MA 02141 401 307-3092 Common Stock, Par Value $0.001 Yes No Non-accelerated Filer true false false 586385063

6838

26342

6838

26342

6838

26342

187552

196794

1322046

1141681

31425

13942

1105758

951532

2660723

2335374

1000 1000

2661723

2336374

600

0.001

1200 1200

583

699600

5000

0.001

1200 1200

68400

500

0.001

1200

253

210

303600

252000

303600

252000

0.001

10000000

100

1207

0.001

10000000000

586385063

586285063

586386

586286

8730313

8733193

-13043185

-12649512

-3726485

-3330032

6838

26342

12205

50000

56224

14585

7365

15468

63589

92258

-97220

15764

-16866

-14224

49084

75375

597

8882

-162573

-64953

-226162

-157211

-226162

-157211

167511

23102

-393673

-180313

-0.00

586292841

556489737

100

1207

586285063

586286

8733193

-12649512

-3330032

100000

100

-20

-2860

167511

-226162

100

1207

586385063

586386

8730313

-13043185

-3726485

25845

555015293

555016

7306031

-11208252

-3347179

-9200

300000

300

360

5000000 5000 1000 6000

23102

-157211

25845

560315293

560316

7297891

-11388565

-3530332

-226162

-157211

1295

12205

100

8600

12000

-97220

15764

-0

15000

-9242

-34827

12854

38986

57006

69825

0 360

31599

-59624

-56532

43000 60000

2880

9200

40120

50800

-19504

-5732

26342

23593

6838

17861

167511 23102 80 6360

NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Unless otherwise indicated, any reference to “the Company”, “we”, “us”, or “its” refers to IIOT-OXYS, Inc., a Nevada corporation, and as applicable to its wholly owned subsidiaries, OXYS Corporation, a Nevada corporation, and HereLab, Inc., a Delaware corporation. IIOT-OXYS, Inc., incorporated in Nevada on July 6, 2017, (the “Company”) was established for the purpose of designing, building, testing, and selling Edge Computing Systems for the Industrial Internet. The Company is currently devoting substantially all its efforts in identifying, developing and marketing engineered products, software and services for applications in the Industrial Internet which involves collecting and processing data collected from a wide variety of industrial systems and machines. On October 30, 2025, the Company had a change of control in management, and the Company and its debtholders mutually agreed to convert their convertible promissory notes due, and compensation due to officers in exchange for issuance of Series E Preferred Stock in full settlement of all balances due (Note 3, Note 6 and Note 7). Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company. The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Going Concern The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements as of March 31, 2026, the Company has suffered continuing operating losses, has a (a) working capital deficit of $2,653,885, (b) net loss from operations for the three months ended March 31, 2026 of $393,673, (c) cash used in operating activities of $59,624, and (d) accumulated deficit of $13,043,185. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company will be able to achieve a satisfactory level of liquidity to meet the Company’s obligations for the next twelve months by generating cash through additional borrowings and/or sale of equity securities, as needed. However, there can be no assurance that the Company will be able to generate sufficient liquidity to maintain its operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company. The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.

Going Concern The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements as of March 31, 2026, the Company has suffered continuing operating losses, has a (a) working capital deficit of $2,653,885, (b) net loss from operations for the three months ended March 31, 2026 of $393,673, (c) cash used in operating activities of $59,624, and (d) accumulated deficit of $13,043,185. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company will be able to achieve a satisfactory level of liquidity to meet the Company’s obligations for the next twelve months by generating cash through additional borrowings and/or sale of equity securities, as needed. However, there can be no assurance that the Company will be able to generate sufficient liquidity to maintain its operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. -2653885

-393673

-59624

-13043185

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The following summary of the significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. These accounting policies conform to the generally accepted accounting principles (the “GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements. Interim Financial Statements The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with GAAP for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2025, filed with the SEC on May 11, 2026. Principles of Consolidation The consolidated condensed financial statements for March 31, 2026 and 2025, respectively, include the accounts of the Company, and its wholly owned subsidiaries OXYS Corporation and HereLab, Inc. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related parties. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Basic and Diluted Earnings (Loss) Per Common Share The Company computes earnings (loss) per share in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”), ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Revenue Recognition The Company recognizes revenue when the products are delivered to the customer or services are performed in accordance with the contractual terms of the contract with its customer. The Company recognizes revenue in accordance with ASC Topic No. 606, Revenue from Contracts with Customers, which was adopted on January 1, 2018. The Company recognizes revenue based on the following criteria of ASC 606: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Identification of a contract or contracts with a customer.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Identification of the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Determination of contract price.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Allocation of transaction price to the performance obligation.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Recognition of revenue when, or as, performance obligation is satisfied.</td></tr> </table> The Company used a practical expedient available under ASC 606-10-65-1(f)4 that permits it to consider the aggregate effect of all contract modifications that occurred before the beginning of the earliest period presented when identifying satisfied and unsatisfied performance obligations, transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations. The Company has elected to treat shipping and handling activities as the cost of sales. Additionally, the Company has elected to record revenue net of sales and other similar taxes. Segment Information The Company’s Chief Executive Officer (“CEO”) is our chief operating decision maker (“CODM”) and evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis. The Company is devoting all its efforts to identifying technologies in developing and marketing engineered products, software and services for applications in the Industrial Internet, which involves collecting and processing data collected from a wide variety of industrial systems and machines. The Company’s CODM has determined that it operates as a single reportable segment. Recent Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40); Disaggregation of Income Statement Expenses. ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026. The Company is currently evaluating the impact, if any, that the updated standard will have on the consolidated financial statements.

Interim Financial Statements The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with GAAP for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2025, filed with the SEC on May 11, 2026.

Principles of Consolidation The consolidated condensed financial statements for March 31, 2026 and 2025, respectively, include the accounts of the Company, and its wholly owned subsidiaries OXYS Corporation and HereLab, Inc. All significant intercompany balances and transactions have been eliminated.

Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related parties. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Basic and Diluted Earnings (Loss) Per Common Share The Company computes earnings (loss) per share in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”), ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.

Revenue Recognition The Company recognizes revenue when the products are delivered to the customer or services are performed in accordance with the contractual terms of the contract with its customer. The Company recognizes revenue in accordance with ASC Topic No. 606, Revenue from Contracts with Customers, which was adopted on January 1, 2018. The Company recognizes revenue based on the following criteria of ASC 606: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">Identification of a contract or contracts with a customer.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Identification of the performance obligations in the contract.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Determination of contract price.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Allocation of transaction price to the performance obligation.</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">Recognition of revenue when, or as, performance obligation is satisfied.</td></tr> </table> The Company used a practical expedient available under ASC 606-10-65-1(f)4 that permits it to consider the aggregate effect of all contract modifications that occurred before the beginning of the earliest period presented when identifying satisfied and unsatisfied performance obligations, transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations. The Company has elected to treat shipping and handling activities as the cost of sales. Additionally, the Company has elected to record revenue net of sales and other similar taxes.

Segment Information The Company’s Chief Executive Officer (“CEO”) is our chief operating decision maker (“CODM”) and evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis. The Company is devoting all its efforts to identifying technologies in developing and marketing engineered products, software and services for applications in the Industrial Internet, which involves collecting and processing data collected from a wide variety of industrial systems and machines. The Company’s CODM has determined that it operates as a single reportable segment.

Recent Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40); Disaggregation of Income Statement Expenses. ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026. The Company is currently evaluating the impact, if any, that the updated standard will have on the consolidated financial statements.

NOTE 3 – COMMITMENTS AND CONTINGENCIES 2017 Stock Incentive Plan & 2019 Stock Incentive Plan In prior years, the Company entered into consulting agreements with one director, three executive officers, and one engineer of the Company, which included commitments to issue shares of the Company’s common stock from the Company’s 2017 Stock Incentive Plan (“2017 Plan”) and 2019 Stock Incentive Plan (“2019 Plan”). The authorized shares pursuant to the 2017 Plan were <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zBJmdFuYe8Nf" title="Shares authorized under plan">4,500,000 shares, and per 2019 Plan were <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zWADLclHnKAb">5,000,000 shares. In the event that a consulting agreement is terminated by either party pursuant to the terms of the agreement, all unvested shares which have been earned shall vest on a pro-rata basis as of the effective date of the termination of the agreement and all unearned, unvested shares shall be terminated. The value of the shares was assigned to a fair market value on the effective date of the agreement and the pro-rata number of shares earned was calculated and amortized at the end of each reporting period. The consulting agreements with two consultants have been terminated and shares have been issued in conjunction with the related separation agreements. According to the terms of the agreements, <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zUpP5FM44oui" title="Stock vested, shares"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_za5Lx685zJ2e" title="Stock vested, shares">3,547,788 shares were vested and issued per the Company’s 2017 Plan as of December 31, 2025 and 2024, and <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20241231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zvwFJ05m2nKj" title="Stock vested, shares"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zyISvNPEHjmf" title="Stock vested, shares">3,530,000 shares were vested and issued per the Company’s 2019 Plan as of December 31, 2025 and 2024, respectively. 2022 Stock Incentive Plan On March 18, 2022, the Company adopted 2022 Stock Incentive Plan (“2022 Plan”) and reserved 20,000,000 shares of common stock for issuance to incentivize its management team. Pursuant to the terms of the 2022 Plan, <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z4HqtBgDHPgf">14,300,000 shares of common stock were vested and 14,200,000 shares and 3,100,000 were issued as of December 31, 2025 and 2024, respectively. 100,000 shares vested remained to be issued to an advisor pursuant to 2022 Plan as of December 31, 2025, and were issued to the advisor on March 24, 2026. On October 30, 2025, the Company had a change in control of management and all unvested shares pursuant to the 2017 Plan, 2019 Plan, and 2022 Plan were forfeited and cancelled. The Board of Directors subsequently terminated each of the 2017 Plan, the 2019 Plan, and the 2022 Plan effective December 31, 2025. As of December 31, 2025, there were no unvested shares remaining under any of the Plans. Employment Agreement – CEO On October 30, 2025, the Company had a change in control of the management, and the Employment Agreement of Mr. Cliff Emmons, CEO of the Company, was terminated. The Company entered into a Consulting Agreement with Mr. Emmons pursuant to which Mr. Emmons will receive a monthly fee of $<span id="xdx_90C_ecustom--MonthlyConsultingFee_c20251029__20251030__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmmonsMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zRa4cHfcdPEd" title="Monthly consulting fee">4,167 payable in Series E Preferred Stock issuable no later than 15 days following the end of the month. The term of the Consulting Agreement was for three months which is automatically renewable upon the consent of the parties for additional one-month terms. The Company recorded $12,500 in Consulting fees expense for the three months ended March 31, 2026. Consulting fees and reimbursable expenses payable to Mr. Emmons totaled $25,068 and $8,402 at March 31, 2026 and December 31, 2025, respectively.

4500000

5000000

3547788

3530000

20000000

14300000

14200000 3100000 4167 12500

25068

8402

NOTE 4 – CONVERTIBLE NOTES PAYABLE The following table summarizes the outstanding balance of convertible note payable, interest and conversion rates as of March 31, 2026 and December 31, 2025, respectively. <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ConvertibleDebtTableTextBlock_zqJT58lrTUH9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details - Outstanding balance)"> <tr style="vertical-align: bottom"> <td>Schedule of outstanding balance of convertible notes payable</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026 (Unaudited)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Convertible note payable (Note “G”) to an investor with interest at 10% per annum, convertible at any time into shares of common stock at $0.0006 per share. Note was issued as payment for future fees to be incurred under the related Equity Financing Agreement. Principal and interest due on maturity on October 31, 2026. The note is secured by substantially all the assets of the Company.</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20260331__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_z6q68Z5XCiU" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Convertible note payable, gross">13,942</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zDYUEkC6mfS2" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Convertible note payable, gross">13,942</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20260331_zHqopNT2P5r7" style="text-align: right" title="Convertible notes payable">13,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231_zzA0yq5hSEb6" style="text-align: right" title="Convertible notes payable">13,942</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20260331_zgnu7KwZidrf" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(13,942</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20251231_zcOYEkMCZyy5" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(13,942</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_c20260331_zhVtOx15pkzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_c20251231_zKhwGDsTvLxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> July 2020 Equity Financing Arrangement (“Note G”) On October 29, 2025, the noteholder of Note G agreed to extend the maturity date of the Secured Convertible Promissory Note from October 29, 2025 to April 29, 2026, and then further extended to October 31, 2026. All other terms and conditions of the Note G remained the same. The Company recorded interest expense on Note G of $344 and $344 for the three months ended March 31, 2026 and 2025, respectively. Accrued interest payable on Note G was $2,861 and $2,517 as of March 31, 2026 and December 31, 2025, respectively. The principal balance payable of Note G totaled $13,942 as of March 31, 2026 and December 31, 2025, respectively.

<table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ConvertibleDebtTableTextBlock_zqJT58lrTUH9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONVERTIBLE NOTES PAYABLE (Details - Outstanding balance)"> <tr style="vertical-align: bottom"> <td>Schedule of outstanding balance of convertible notes payable</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2026 (Unaudited)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Convertible note payable (Note “G”) to an investor with interest at 10% per annum, convertible at any time into shares of common stock at $0.0006 per share. Note was issued as payment for future fees to be incurred under the related Equity Financing Agreement. Principal and interest due on maturity on October 31, 2026. The note is secured by substantially all the assets of the Company.</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20260331__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_z6q68Z5XCiU" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Convertible note payable, gross">13,942</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesPayableGMember_zDYUEkC6mfS2" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Convertible note payable, gross">13,942</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20260331_zHqopNT2P5r7" style="text-align: right" title="Convertible notes payable">13,942</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20251231_zzA0yq5hSEb6" style="text-align: right" title="Convertible notes payable">13,942</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20260331_zgnu7KwZidrf" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(13,942</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayableCurrent_iNI_di_c20251231_zcOYEkMCZyy5" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(13,942</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_c20260331_zhVtOx15pkzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pp0p0_d0_c20251231_zKhwGDsTvLxd" style="border-bottom: Black 2.5pt double; text-align: right" title="Long term portion">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

13942

344

2861

2517

13942

NOTE 5 – EARNINGS (LOSS) PER SHARE The following table sets forth the computation of basic and diluted net loss per share of common stock for the three months ended March 31, 2026 and 2025, respectively: <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z06M4QnD1nyj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Per share information)"> <tr style="vertical-align: bottom"> <td>Schedule of computation of basic and diluted net loss per share of common stock</td><td> </td> <td colspan="2" id="xdx_49B_20260101__20260331_z1lLnxKv5Gai" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zQKRRRv460Jc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders (basic)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(393,673</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(180,313</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Shares used to compute net loss per common share, basic and diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">586,292,841</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">556,489,737</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company’s potentially dilutive securities, which include stock options, convertible debt, convertible preferred stock and common stock warrants have been excluded from the computation of diluted net loss per share as they would be anti-dilutive. For all periods presented, there is no difference in the number of shares used to compute basic and diluted shares outstanding due to the Company’s net loss position. The following outstanding common stock equivalents have been excluded from diluted net loss per common share for the three months ended March 31, 2026 and 2025, respectively, because their inclusion would be anti-dilutive: <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zNRhhhWLejkl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td>Schedule of anti-dilutive shares</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Potentially issuable shares related to convertible notes payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_z1CI5eIgNyP9" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">18,670,141</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zxOnIiI1ykC1" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">777,016,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Potentially issuable vested shares to directors and officers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_z7GwgMvZPCkc" style="text-align: right" title="Total anti-dilutive common stock equivalents">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_z1yJKs1sOSig" style="text-align: right" title="Total anti-dilutive common stock equivalents">8,200,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Potentially issuable unvested shares to directors and officers</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_zOgkrNZ4uIFa" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_zyg9YXf54S4c" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">6,100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total anti-dilutive common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_z8doJoXCuRkf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">18,670,141</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zJW57Zg9xUul" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">791,316,043</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z06M4QnD1nyj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Per share information)"> <tr style="vertical-align: bottom"> <td>Schedule of computation of basic and diluted net loss per share of common stock</td><td> </td> <td colspan="2" id="xdx_49B_20260101__20260331_z1lLnxKv5Gai" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zQKRRRv460Jc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">Net loss attributable to common stockholders (basic)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(393,673</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">(180,313</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Shares used to compute net loss per common share, basic and diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">586,292,841</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">556,489,737</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

-393673

-180313

586292841

556489737

-0.00

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zNRhhhWLejkl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS (LOSS) PER SHARE (Details - Antidilutive shares)"> <tr style="vertical-align: bottom"> <td>Schedule of anti-dilutive shares</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Potentially issuable shares related to convertible notes payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_z1CI5eIgNyP9" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">18,670,141</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zxOnIiI1ykC1" style="width: 13%; text-align: right" title="Total anti-dilutive common stock equivalents">777,016,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Potentially issuable vested shares to directors and officers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_z7GwgMvZPCkc" style="text-align: right" title="Total anti-dilutive common stock equivalents">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--VestedSharesToDirectorsAndOfficersMember_z1yJKs1sOSig" style="text-align: right" title="Total anti-dilutive common stock equivalents">8,200,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Potentially issuable unvested shares to directors and officers</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d0_c20260101__20260331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_zOgkrNZ4uIFa" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedSharesToDirectorsAndOfficersMember_zyg9YXf54S4c" style="border-bottom: Black 1pt solid; text-align: right" title="Total anti-dilutive common stock equivalents">6,100,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total anti-dilutive common stock equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20260101__20260331_z8doJoXCuRkf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">18,670,141</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20250101__20250331_zJW57Zg9xUul" style="border-bottom: Black 2.5pt double; text-align: right" title="Total anti-dilutive common stock equivalents">791,316,043</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

18670141

777016043

8200000

6100000

18670141

791316043

NOTE 6 – RELATED PARTIES The Company executed a Convertible Promissory Note (“Note”) payable to its CEO and director (“Officer”) and indebted in the principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--OfficerAndDirectorMember_zN9eBVcPaep3">55,000 as of December 31, 2023. On February 5, 2024, the Company and the Officer entered into a Debt Exchange Agreement to convert $<span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240204__20240205__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NoteholderMember_zva5LmTyG4Zk">55,000 principal balance of Note and $<span id="xdx_906_ecustom--DebtConversionConvertedAccruedAndUnpaidInterestAmount_c20240204__20240205__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NoteholderMember_z2nMg4MUwz65">13,825 of accrued and unpaid interest as of the maturity date of Note on <span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20240204__20240205__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NoteholderMember_zjiBQUmxHJed">March 1, 2024. In exchange for the cancellation of all indebtedness of the Company owed the Officer as evidenced by the Note, and for no additional consideration, the Company agreed to issue to Officer <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240204__20240205__us-gaap--LongtermDebtTypeAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NoteholderMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z7MiIkHtEpui">57 shares of the Company’s Series C Convertible Preferred Stock, at the stated value of $1,200 per share (See Note 7). Accrued dividend payable on this Convertible Preferred Stock (including default for non-payment of dividend) totaled $30,547 and $26,330 as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company had a change in control and GHS Investments, LLP became the majority owner of the issued and outstanding shares of common and preferred stock (See Note 5 and Note 8). On October 30, 2025, the Company entered into a Consulting Agreement (the “Consulting Agreement”) with its Officer, pursuant to which the Officer agreed to receive a monthly fee of $<span id="xdx_90C_ecustom--MonthlyConsultingFee_c20251029__20251030__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmmonsMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zkggco6duiwe">4,167 payable in Series E Preferred Stock issuable no later than 15 days following the end of the month. The term of the Consulting Agreement is for three months, which is automatically renewable upon the consent of the parties for additional one-month terms. The Company has not issued Series E Preferred Stock for the Officer’s unpaid compensation as of March 31, 2026. The Company has recorded consulting fees expense of $<span id="xdx_901_ecustom--ConsultingFeesExpense_c20260101__20260331__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zh8MgU5cyBKb">12,500 for the three months ended March 31, 2026. Consulting fees and reimbursable expenses payable to the Officer totaled $<span id="xdx_90B_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_c20260331__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_znilndJetSMb">25,068 and $<span id="xdx_900_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_c20251231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zysZrUwrFroa">8,402 as of March 31, 2026 and December 31, 2025, respectively. The expected number of Series E Preferred Stock to be issued totaled 21 shares and 7 shares as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Emmons DEA”) with Clifford L. Emmons, it’s Chief Executive Officer and Director. Pursuant to the Emmons DEA, Mr. Emmons exchanged $<span id="xdx_908_eus-gaap--DebtConversionOriginalDebtAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--TransactionTypeAxis__custom--AccruedCompensationAndUnpaidFeesMember_z1e7AKmQdpNc" title="Debt converted, amount converted">387,242 of accrued compensation and unpaid fees owed to him by the Company under various agreements, for <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zbysR3pXaMNd" title="Debt converted, shares issued">269 shares of the Company’s Series E Convertible Preferred Stock (the “Series E Preferred Stock”). In addition to the issuance of the Company’s Series E Preferred Stock, Mr. Emmons agreed to cancel <span id="xdx_90D_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2HInTzuLP6j" title="Stock cancelled during period">7,800 shares of Series A Preferred Stock owned by him. The closing of the Emmons DEA occurred on November 5, 2025. The Company recorded dividend expense of $4,217 for the three months ended March 31, 2026, The Company recorded $30,547 and $26,330 as dividend payable to Mr. Emmons as of March 31, 2026 and December 31, 2025, respectively (Note 7).

55000

13825

2024-03-01

30547

26330

4167 12500

25068

8402

387242

269

7800

4217

30547

26330

NOTE 7 – STOCKHOLDERS' EQUITY The Company has an authorized capital of 10,000,000,000 shares, $0.001 par value common stock, and 10,000,000 shares of $0.001 par value preferred stock at March 31, 2026. The Company has 586,385,063 shares of common stock, 100 shares of Series A Preferred Stock, 583 shares of Series B Preferred Stock, 57 shares of Series C Preferred Stock, 253 shares of Series D Preferred Stock, and 1,207 shares of Series E Preferred Stock issued and outstanding as of March 31, 2026. Common Stock Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights. Holders of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the Board of Directors in its discretion of funds legally available, therefore. In the event of liquidation, dissolution, or winding up of the Company, the holders of common stock are entitled to share pro rata in all assets remaining after payment in full of all liabilities. All of the outstanding shares of common stock are fully paid and non-assessable. Holders of common stock have no preemptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund provisions with respect to the common stock. Stock Incentive Plans On December 14, 2017, the Board of Directors of the Company approved the 2017 Stock Incentive Plan (the “2017 Plan”). Awards may be made under the 2017 Plan for up to 4,500,000 shares of common stock of the Company. All the Company’s employees, officers and directors, as well as consultants and advisors to the Company are eligible to be granted awards under the 2017 Plan. No awards can be granted under the 2017 Plan after the expiration of 10 years from the plan approval, but awards previously granted may extend beyond that date. Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation rights, and restricted stock awards. On October 30, 2025, the Company cancelled <span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCancelled_iI_c20251030__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_ze8FuY0iVwIk" title="Shares cancelled under the plan">952,212 unissued shares pursuant to the 2017 Plan. As of March 31, 2026 and December 31, 2025, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zWFFeJjf5Lel" title="Shares outstanding"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2017Member_zzSopSMvnK63" title="Shares outstanding">0 shares remain unissued or unvested pursuant to the 2017 Plan. On March 11, 2019, the Board of Directors of the Company approved the 2019 Stock Incentive Plan (the “2019 Plan”). Awards may be made under the 2019 Plan for up to <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20190311__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zmzZxgfKXmFj" title="Shares authorized under the plan">5,000,000 shares of common stock of the Company. All of the Company’s employees, officers and directors, as well as consultants and advisors to the Company are eligible to be granted awards under the 2019 Plan. No awards can be granted under the 2019 Plan after the expiration of 10 years from the plan approval but awards previously granted may extend beyond that date. Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation rights, and restricted stock awards. On October 30, 2025, the Company cancelled <span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCancelled_iI_c20251030__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zB07akQ4sHr9" title="Shares cancelled under the plan">1,270,000 unissued shares pursuant to the 2019 Plan. As of March 31, 2026 and December 31, 2025, <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_zlJUjJcSf9Dc" title="Shares outstanding"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2019Member_znMROKdMzjzl" title="Shares outstanding">0 shares remain unissued or unvested pursuant to the 2019 Plan. On March 18, 2022, the Board of Directors adopted the 2022 Stock Incentive Plan (the “2022 Plan”), under which <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20220318__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zPVkFzVOCrUl" title="Shares authorized under the plan">20,000,000 shares of common stock were authorized for issuance. The Company has awarded <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220319__20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z6Kz2vd2ged7" title="Shares granted">14,300,000 shares under the 2022 Plan, of which <span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedNumber_iI_c20251231__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zkrStpGz1ZU6" title="Shares issued under plan">14,200,000 were issued as of December 31, 2025 and <span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedNumber_iI_c20260324__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zIcOvcUlzXi" title="Shares issued under plan">100,000 shares were issued on March 24, 2026. In connection with the change of control on October 30, 2025, <span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCancelled_iI_c20251030__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zkK5268YKTw8" title="Shares cancelled under the plan">6,000,000 unvested shares were cancelled. The 2022 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors. Shares earned and issued related to the consulting agreements are issued under the 2017 Stock Incentive Plan and the 2019 Stock Incentive Plan (see Note 3). A summary of the status of the Company’s non-vested shares at March 31, 2026 and 2025 and changes during the three months ended, is presented below: <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z9nW5trc4Vfj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Non-vested shares)"> <tr style="vertical-align: bottom"> <td>Schedule of non-vested shares</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">2022 Stock Incentive Plan</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Authorized shares per the 2022 Plan – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLSE9MREVSUycgRVFVSVRZIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z2VKhmxfBYb5" title="Authorized shares">20,000,000 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%">Balance - December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zlIiv7HQdKCd" style="width: 13%; text-align: right" title="Shares of common stock, Beginning balance">11,200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zjrZoDStgrYe" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Awarded</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zW2IHhT88imh" style="text-align: right" title="Shares of common stock, Awarded">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zBVuP52GokGf" style="text-align: right" title="Weighted average exercise price, Awarded">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_iN_di_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zr8xK8OOW4Wa" style="text-align: right" title="Shares of common stock, Issued">(5,100,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z0YevUJfnj99" style="text-align: right" title="Weighted average exercise price, Issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zXYntveLSkF9" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zWeER8HVYOj4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance – March 31, 2025 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_ztQRF34Fafwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">6,100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zCSCFDNsO8f8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">0.006146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance - December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zjX6ZB44vH54" style="text-align: right" title="Shares of common stock, Beginning balance">6,100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zCMU0D9EmlUf" style="text-align: right" title="Weighted average exercise price, Beginning balance">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Awarded</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z4OiPYyLRzJl" style="text-align: right" title="Shares of common stock, Awarded">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z2RNDwctVaAf" style="text-align: right" title="Weighted average exercise price, Awarded">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_iN_di_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zN9BBaO569U4" style="text-align: right" title="Shares of common stock, Issued">(100,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z2UgoNsouBP1" style="text-align: right" title="Weighted average exercise price, Issued">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zSbtIn24m3sd" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">(6,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zzMiwaoBQMki" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance – March 31, 2026 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zdLZTeL3hA0d" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zUavEUcrksC" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Preferred Stock Series A Supervoting Convertible Preferred Stock The Board of Directors of the Company authorized the issuance of 25,845 shares of preferred stock, $0.001 par value per share, designated as Series A Supervoting Preferred Stock. On October 30, 2025, the Company entered into a Stock Purchase Agreement with GHS Investments, LLC, a Nevada limited liability company (“GHS”), pursuant to which, upon occurrence of certain conditions, including defaults by the Company under its agreements with GHS and subsequent waivers and extensions thereof by GHS, the Company would issue to GHS 100 shares of the Company’s Series A Supervoting Preferred Stock. On November 5, 2025, the closing of the Stock Purchase Agreement occurred, and GHS was issued 100 shares of Series A Supervoting Preferred Stock. Dividends: Initially, there will be no dividends due or payable on Series A Supervoting Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Company’s Articles of Incorporation. Liquidation and Redemption Rights: Upon the occurrence of a Liquidation Event (as defined below), the holders of Series A Supervoting Preferred Stock are entitled to receive net assets on a pro-rata basis. Each holder of Series A Supervoting Preferred Stock is entitled to receive ratably any dividends declared by the Board, if any, out of funds legally available for the payment of dividends. Liquidation Event means (i) the liquidation, dissolution or winding-up, whether voluntary or involuntary, of the Company, (ii) the purchase or redemption by the Company of the shares of any class of stock or the merger or consolidation of the Company with or into any other corporation or corporations, or (iii) the sale, license or lease of all or substantially all, or any material part of, the Company’s assets. Conversion: Each holder of Series A Supervoting Preferred Stock may voluntarily convert its shares into shares of common stock of the Company at a rate of 1:100 (as may be adjusted for any combinations or splits with respect to such shares). Rank: All shares of the Series A Supervoting Preferred Stock shall rank senior to the Company’s (A) common stock, par value $0.001 per share, and any other class or series of capital stock of the Company hereafter created. Voting Rights: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">A.</td> <td style="text-align: justify">If at least one share of Series A Super Voting Preferred Stock is issued and outstanding, then the total aggregate issued shares of Series A Super Voting Preferred Stock at any given time, regardless of their number, shall have voting rights equal to 20 times the sum of: i) the total number of shares of Common stock which are issued and outstanding at the time of voting, plus ii) the total number of shares of all Series of Preferred stocks which are issued and outstanding at the time of voting.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>B.</td> <td style="text-align: justify">Each individual share of Series A Super Voting Preferred Stock shall have the voting rights equal to:</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify">[twenty times the sum of: {all shares of Common stock issued and outstanding at the time of voting + all shares of Series A and any newly designated Preferred stock issued and outstanding at the time of voting}]</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify">Divided by:</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify">[the number of shares of Series A Super Voting Preferred Stock issued and outstanding at the time of voting]</td></tr> </table> With respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of the outstanding shares of Series A Super Voting Preferred Stock shall vote together with the holders of Common Stock without regard to class, except as to those matters on which separate class voting is required by applicable law or the Articles of Incorporation or Bylaws. The Company had 100 shares of Series A Preferred Stock issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock Equity Financing On November 16, 2020, the Board of Directors of the Company had authorized issuance of up to 600 shares of preferred stock, $0.001 par value per share, designated as Series B Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series B Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series B Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series B Convertible Preferred Stock. From and after the initial Closing Date, in addition to the payment of dividends pursuant to Section 2(a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series B Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights: The Series B Convertible Preferred Stock will vote together with the common stock on an as converted basis subject to the Beneficial Ownership Limitations (not in excess of 4.99% conversion limitation). However, as long as any shares of Series B Convertible Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Series B Convertible Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Series b Convertible Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise Pari passu with, the Series B Convertible Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise Pari passu with, the Series b Convertible Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Series B Convertible Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing. Liquidation: Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Series B Convertible Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. Conversion: Each share of Series B Convertible Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of common stock (subject to the limitations) determined by dividing the Stated Value of such share of Series B Convertible Preferred Stock by the Conversion Price. The Conversion Price for the Series B Convertible Preferred Stock shall be the amount equal to the lowest traded price for the Company’s common stock for the fifteen (15) Trading Days immediately preceding the date of such conversion. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the common stock during such a measuring period. Following an event of default, the Conversion price shall equal the lower of : (a) the then applicable Conversion Price; or (b) a price per share equaling 80% of the lowest traded price for the Company’s common stock during the ten (10) trading days preceding the relevant Conversion. Redemption: The Series B Convertible Preferred Stock may be redeemed by payment of the stated value thereof, with the following premiums based on the time of the redemption. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">·</td> <td style="text-align: justify">115% of the stated value if the redemption takes place within 90 days of issuance</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">120% of the stated value if the redemption takes place after 90 days and within 120 days of issuance</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">125% of the stated value if the redemption takes place after 120 days and within 180 days of issuance; and</td></tr> <tr style="vertical-align: top"> <td> </td> <td>·</td> <td style="text-align: justify">each share of Preferred Stock is redeemed one year from the day of issuance</td></tr> </table> November 19, 2020 On November 19, 2020, pursuant to the terms of a Securities Purchase Agreement dated November 16, 2020 (the “SPA”), the Company entered into a new preferred equity financing agreement with GHS Investments, LLC (“GHS”) in the amount of up to $600,000. The SPA provides for GHS’s purchase, from time to time, of up to 600 shares of the newly designated Series B Convertible Preferred Stock. The initial closing under the SPA consisted of 45 shares of Series B Convertible Preferred Stock, stated value $1,200 per share, issued to GHS for an initial purchase price of $45,000, or $1,000 per share. At the Company’s option, and subject to the terms of the SPA and the Certificate of Designation for the Series B Convertible Preferred Stock (the “COD”), additional closings in the amount of 40 shares of Series B Convertible Preferred Stock for a total purchase price of $40,000 may take place at a rate of up to once every 30 days. In connection with the initial closing in the amount of 45 shares of Series B Convertible Preferred Stock, the Company issued an additional 25 shares of Series B Convertible Preferred Stock to GHS as a commitment fee. No additional closing may take place after the two-year anniversary of the SPA, or once the entire $600,000 amount has been funded. If the average daily dollar trading volume for the Company’s common stock for the 30 trading days preceding a particular additional closing is at least $50,000 per day, the Company may, at its option, increase the amount of that additional closing to 75 shares of Series B Convertible Preferred Stock ($75,000). The Series B Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging, the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results for each reporting period. On November 19, 2020, GHS purchased a total of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_z7nAVS5J57of" title="Stock issued new, shares">70 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zQL4TTrBIL98" title="Proceeds from sale of stock">45,000. The Company paid $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zM43H67q9Oie" title="Payments of stock issuance costs">900 in selling commissions to complete this financing. On November 19, 2020 (the date of receipt of cash proceeds of $45,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90A_ecustom--DerivativeLiabilityCurrent_c20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Derivative liability payable">103,267, $<span id="xdx_902_ecustom--DayOneLossOnDerivative_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Day one loss on derivative">58,267 as day one loss on the derivative, $<span id="xdx_900_eus-gaap--InterestExpenseOther_pp0p0_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_z1mPMwOH1dfl">39,000 as interest expense, and $<span id="xdx_900_ecustom--MezzanineDerivativeLiability_c20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Mezzanine derivative liability">39,000 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_909_eus-gaap--InterestExpenseDebt_pp0p0_c20201118__20201119__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zPXnY6suIRQ8" title="Interest expense">45,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a loss in connection with the change in fair market value of the derivative liability of $<span id="xdx_904_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_z0OFJ5S0Dgak" title="Loss on derivative liability">6,630 for the three months ended March 31, 2026, and a gain of $<span id="xdx_90B_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_z8P0o5lc5JN1" title="Gain on derivative liability">2,751 for the three months ended March 31, 2025, respectively. The Company recorded preferred dividend expense of $<span id="xdx_906_eus-gaap--DividendsPreferredStock_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zcht8mzNrQu7" title="Dividends, preferred stock">18,334 and $<span id="xdx_90F_eus-gaap--DividendsPreferredStock_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zi5ET4FN8oHl" title="Dividends, preferred stock">2,485 for the three months ended March 31, 2026 and 2025, respectively. The Company recorded $<span id="xdx_90C_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_zA0kT9Xajygj" title="Preferred stock dividend payable">197,874 and $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_ztUgmfyHXiYl" title="Preferred stock dividend payable">179,540 as preferred stock dividend payable as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $139,406 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $139,406 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_90B_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Derivative liability payable">84,947 and $<span id="xdx_90A_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Derivative liability payable">78,317 at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_901_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_900_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2020Member_pp0p0" title="Mezzanine derivative liability">84,000 at March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0141, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0184, an expected dividend yield of 0%, expected volatility ranging from 160.41% to 440.99%, risk-free interest rates ranging from 0.07% to 5.46%, and an expected term ranging from 0.13 years to 1.50 years. December 16, 2020 On December 16, 2020, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zifqPx91162a" title="Stock issued new, shares">85 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zZQ8V1h6haw5" title="Issuance sale equity">85,000. The Company paid $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zKmsMLAK35K9" title="Issuance cost">1,700 in selling commissions to complete this financing. On December 16, 2020 (the date of receipt of cash proceeds of $85,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90E_ecustom--DerivativeLiabilityCurrent_c20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Derivative liability payable">106,241, $<span id="xdx_90B_ecustom--DayOneLossOnDerivative_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Day one loss on derivative">21,241 as day one loss on the derivative, $<span id="xdx_905_eus-gaap--InterestExpenseOther_pp0p0_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zGgXpWk0L8a1" title="Interest expense">17,000 as interest expense, and $<span id="xdx_90E_ecustom--MezzanineDerivativeLiability_c20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Mezzanine derivative liability">17,000 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_pp0p0_c20201215__20201216__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zrVYkx218wQf">85,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a loss of $<span id="xdx_901_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zebwLtlTvNh" title="Loss on derivative liability">8,050 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_900_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zFwy3T4y6Vve" title="Gain on derivative liability">3,341 for the three months ended March 31, 2025, respectively. The Company recorded preferred dividend expense of $<span id="xdx_908_eus-gaap--Dividends_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zsy4bWgMkSK8" title="Preferred stock dividend expense">21,814 and $<span id="xdx_904_eus-gaap--Dividends_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zap8QEZigQZ9" title="Preferred stock dividend expense">3,018 for the three months ended March 31, 2026 and 2025, respectively. The Company recorded $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_zM0zNFmNSPl5" title="Preferred stock dividend payable">237,789 and $<span id="xdx_903_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_z8HBistDfn72" title="Preferred stock dividend payable">215,975 as preferred stock dividend payable as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $170,942 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $170,902 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_902_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Derivative liability payable">103,150 and $<span id="xdx_901_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Derivative liability payable">95,099 at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_900_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_90C_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2020Member_pp0p0" title="Mezzanine derivative liability">102,000 at March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0141, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0184, an expected dividend yield of 0%, expected volatility ranging from 160.41% to 437.59%, risk-free interest rates ranging from 0.07% to 5.46%, and an expected term ranging from 0.21 years to 1.50 years. December 20, 2021 On December 20, 2021, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zLLOrnaqfYu1" title="Stock issued new, shares">51 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zHH6DUGMp9Kk" title="Issuance sale equity">51,000. The Company paid $<span id="xdx_90D_eus-gaap--PaymentsOfStockIssuanceCosts_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zmVvIrMzxh" title="Issuance cost">1,000 in selling commissions to complete this financing. For the year ended December 31, 2021, the Company inadvertently reported this sale of <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211219__20211220__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zEBSvMHSvFsk" title="Number of shares sold">51 shares as Series A Preferred stock (See Series A Supervoting Preferred Stock). The accompanying financial statements reflect the correct purchase of Series B Convertible Preferred Stock rather than Series A Convertible Preferred Stock. The overall effect of this correction was not significant to the December 31, 2021 financial statements. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a loss of $<span id="xdx_902_ecustom--DerivativeLossOnDerivative1_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_pp0p0" title="Loss on derivative liability">4,830 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_902_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zqLBqngpmjg6" title="Gain on derivative liability">2,005 for the three months ended March 31, 2025, respectively. The Company recorded preferred dividend expense of $<span id="xdx_906_eus-gaap--Dividends_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zQeyxC0WT3n" title="Preferred stock dividend expense">25,684 and $<span id="xdx_903_eus-gaap--Dividends_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zvYCG1jndsof" title="Preferred stock dividend expense">1,811 for the three months ended March 31, 2026 and 2025, respectively. The Company recorded $<span id="xdx_90C_eus-gaap--DividendsPayableCurrent_iI_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zzQ9H2WLjr2" title="Preferred stock dividend payable">114,954 and $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_zjo5lEfruAO2" title="Preferred stock dividend payable">89,270 as preferred stock dividend payable as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $85,337 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $85,604 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_903_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_pp0p0" title="Derivative liability payable">61,890 and $<span id="xdx_902_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_pp0p0" title="Derivative liability payable">57,060 at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_901_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_900_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember2021Member_pp0p0" title="Mezzanine derivative liability">61,200 at March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0050 the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0070, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 221.64%, risk-free interest rates ranging from 0.91% to 5.46%, and an expected term of 1.50 years. February 7, 2022 On February 7, 2022, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zujsZbK2Dxkd" title="Number of shares issued, shares">51 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zr5R8UEL7Xjg" title="Gross proceeds">51,000. The Company paid $<span id="xdx_906_eus-gaap--PaymentsOfStockIssuanceCosts_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_z4OdxFX4TLcf" title="Selling commissions paid">1,000 in selling commissions to complete this financing. On February 7, 2022 (the date of receipt of cash proceeds of $51,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_901_ecustom--InitialDerivativeLiability_c20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_pp0p0" title="Initial derivative liability">65,025, $<span id="xdx_900_ecustom--DayOneLossOnDerivative_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_pp0p0" title="Day one loss on derivative">14,025 as day one loss on the derivative, $<span id="xdx_909_eus-gaap--InterestExpenseOther_pp0p0_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zFmpyJTBPgui" title="Interest expense">10,200 as interest expense, and $10,200 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_901_eus-gaap--InterestExpenseDebt_pp0p0_c20220206__20220207__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zdX22HHILNI1">51,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_900_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zZnbBiFsDyuf" title="Loss on derivative liability">4,830 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_90F_ecustom--GainOnDerivativeLiability_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_z4KQVd0Culp1" title="Gain on derivative liability">2,005 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $<span id="xdx_90F_eus-gaap--Dividends_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zBqhaoYWSWT">10,560 and $<span id="xdx_90B_eus-gaap--Dividends_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zMUCEXz6wX7i">1,811 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_904_eus-gaap--DividendsPayableCurrent_iI_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zvW2cfqCnpEi" title="Derivative total">93,607 and $<span id="xdx_90C_eus-gaap--DividendsPayableCurrent_iI_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zuGR1fDklzlk" title="Derivative total">83,047 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $64,975 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $82,787 for non-payment of dividend as of March 31, 2026. The Company did not record the waived penalty in its financial statements as of March 31, 2026 and 2025, respectively. Derivative liability payable for this transaction totaled $<span id="xdx_90F_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_pp0p0" title="Derivative liability payable">61,890 and $<span id="xdx_90E_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_pp0p0" title="Derivative liability payable">57,060 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90D_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_90F_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedFebruary2022Member_zjoz6skmkXa8" title="Mezzanine derivative liability">61,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0096, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0172, an expected dividend yield of 0%, expected volatility ranging from 160.35% to 201.38%, risk-free interest rates ranging from 1.09% to 5.46%, and an expected term of 1.35 to 1.5 years. March 24, 2022 On March 24, 2022, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zGlIheKTBaub" title="Number of shares issued, shares">136 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_z1zpthd0QNZ3" title="Gross proceeds">136,000. The Company paid $<span id="xdx_903_eus-gaap--PaymentsOfStockIssuanceCosts_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zVt99S8OtpF" title="Selling commissions paid">2,720 in selling commissions to complete this financing. On March 24, 2022 (the date of receipt of cash proceeds of $136,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_909_ecustom--InitialDerivativeLiability_c20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_pp0p0" title="Initial derivative liability">328,422, $<span id="xdx_901_ecustom--DayOneLossOnDerivative_pp0p0_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zvL7SXqWPFU4" title="Day one gain on derivative">192,422 as day one loss on the derivative, $<span id="xdx_907_eus-gaap--InterestExpenseOther_pp0p0_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zxFfxVUhLNgf">27,200 as interest expense, and $<span id="xdx_90E_ecustom--MezzanineDerivativeLiability_c20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_pp0p0" title="Mezzanine derivative liability">27,200 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90B_eus-gaap--InterestExpenseDebt_pp0p0_c20220323__20220324__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_znUm562coVQj">136,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_90E_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zqtdXT0Zezng" title="Loss on derivative liability">12,880 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_90C_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zjrFefE9AURg" title="Gain on derivative liability">5,345 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $<span id="xdx_90E_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zqlPXa8uY0k4">10,158 and $<span id="xdx_90C_eus-gaap--Dividends_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zqjbkNHWX3p6">4,829 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_902_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_z9FDul04GWK8">215,658 and $<span id="xdx_908_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_zdVE99pSAyxa">205,500 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $141,721 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $213,765 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_90E_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_pp0p0" title="Derivative liability payable">165,040 and $<span id="xdx_901_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_pp0p0" title="Derivative liability payable">152,159 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90C_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_90F_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2022Member_pp0p0" title="Mezzanine derivative liability">163,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0096, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0018, an expected dividend yield of 0%, expected volatility ranging from 160.35% to 202.70%, risk-free interest rates ranging from 1.55% to 5.46%, and an expected term of 1.48 to 1.5 years. November 17, 2022 On November 17, 2022, pursuant to the terms of the SPA, GHS purchased an additional <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zrj4mvnhyV19">61 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Proceeds from sale of equity">61,000. The Company paid $<span id="xdx_90B_eus-gaap--PaymentsOfStockIssuanceCosts_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Payments of stock issuance costs">1,220 in selling commissions to complete this financing. On November 17, 2022 (the date of receipt of cash proceeds of $61,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_902_ecustom--InitialDerivativeLiability_c20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Initial derivative liability">54,072, $<span id="xdx_904_ecustom--DayOneGainOnDerivative_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Day one gain on derivative">6,928 as day one gain on the derivative, $<span id="xdx_90C_eus-gaap--InterestExpenseOther_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0">12,200 as interest expense, $<span id="xdx_90E_ecustom--MezzanineDerivativeLiability_c20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Mezzanine derivative liability">12,200 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_909_eus-gaap--InterestExpenseDebt_pp0p0_c20221116__20221117__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zxmStUohyc8l">61,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_90C_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zeyBcZMPtEtk" title="Loss on derivative liability">5,777 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_90E_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zsl3gY7bRvWj" title="Gain on derivative liability">2,398 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $<span id="xdx_906_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zCIBqySfLOE6">10,267 and $<span id="xdx_908_eus-gaap--Dividends_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zLF2ELjPg25g">2,166 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90F_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zzxtrer2dII3">85,266 and $<span id="xdx_905_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_zAaN8WVOpLK9">74,999 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $57,831 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $85,326 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Derivative liability payable">74,025 and $<span id="xdx_908_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Derivative liability payable">68,248 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_90F_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_90E_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedNovember2022Member_pp0p0" title="Mezzanine derivative liability">73,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0020, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0022, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 201.59%, risk-free interest rates ranging from 3.68% to 5.46%, and an expected term of 1.5 years. August 24, 2023 On August 24, 2023, pursuant to the terms of the SPA, GHS purchased <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zrRMSAz0FDw4">62 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zRFCL9hDEyJe">62,000. The Company paid $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_z7DrfK3S80Lb">1,240 in selling commissions to complete this financing. On August 24, 2023 (the date of receipt of cash proceeds of $62,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90D_ecustom--InitialDerivativeLiability_c20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_pp0p0" title="Initial derivative liability">61,679, $<span id="xdx_906_ecustom--DayOneGainOnDerivative_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_pp0p0" title="Day one gain on derivative">321 as day one gain on the derivative, $<span id="xdx_905_eus-gaap--InterestExpenseOther_pp0p0_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_z3c3LKZYMs18" title="Interest expense">12,400 as interest expense, and $<span id="xdx_903_ecustom--MezzanineDerivativeLiability_c20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_pp0p0" title="Mezzanine derivative liability">12,400 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_c20230823__20230824__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zNJRslw9sjlh">62,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_90F_ecustom--DerivativeLossOnDerivative1_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_pp0p0" title="Loss on derivative liability">5,872 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_903_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zOFzcMwI3ijk" title="Gain on derivative liability">2,440 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $<span id="xdx_903_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zDUuLs2YSLEd" title="Dividends">9,535 and $<span id="xdx_902_eus-gaap--Dividends_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zwbCwd9u6RBa" title="Dividends">2,201 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_901_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zGIEf8ALhub4">72,016 and $<span id="xdx_90E_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_z2Z1GsOMYxe5">62,481 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $50,980 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $75,541 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_907_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zbeMkPjaV8Mk" title="Derivative liability">75,239 and $<span id="xdx_908_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zKO2RXJhWbAc" title="Derivative liability">69,367 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $74,400 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0014, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0015, an expected dividend yield of 0%, expected volatility ranging from 189.98% to 202.70%, risk-free interest rates ranging from 3.68% to 5.46%, and an expected term of 1.5 years. April 16, 2024 On April 16, 2024, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zoRMMwG68Gjc">20 shares of Series B Convertible Preferred Stock for gross proceeds of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zy1sNPrA7Et2">17,600. The Company paid $<span id="xdx_905_eus-gaap--PaymentsOfStockIssuanceCosts_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zcNIQQnbINr3">2,400 in selling commissions to complete this financing. On April 16, 2024 (the date of receipt of cash proceeds of $17,600 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_903_ecustom--InitialDerivativeLiability_iI_pp0p0_c20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_z1mEe7Y4X1Zi" title="Initial derivative liability">20,324, $<span id="xdx_907_ecustom--DayOneLossOnDerivative_pp0p0_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedAugust2023Member_zrZ9XzKMImuc" title="Day one loss on derivative">321 as day one loss on the derivative, $<span id="xdx_906_eus-gaap--InterestExpenseOther_pp0p0_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_z38RPWrRSgF4">4,000 as interest expense, and $<span id="xdx_902_ecustom--MezzanineDerivativeLiability_c20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_pp0p0" title="Mezzanine derivative liability">24,000 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_c20240415__20240416__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zgSiZCw5Zs8g">20,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_907_ecustom--DerivativeLossOnDerivative1_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_pp0p0" title="Loss on derivative liability">1,706 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $<span id="xdx_904_ecustom--DerivativeGainOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zRxeoxtqvqF8" title="Gain on derivative liability">678 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $<span id="xdx_904_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_ziWYgKUapzSe">1,957 and $<span id="xdx_909_eus-gaap--Dividends_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_zRA8d508eI2e">710 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_906_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_znZTpgiSr6Qj">11,767 and $<span id="xdx_90C_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_z2raD7yisgWl">9,810 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $6,843 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $9,915 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_900_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_pp0p0" title="Derivative liability payable">21,575 and $<span id="xdx_901_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_pp0p0" title="Derivative liability payable">19,870 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_900_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_901_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2024Member_pp0p0" title="Mezzanine derivative liability">24,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0009, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0014, an expected dividend yield of 0%, expected volatility ranging from 186.23% to 205.33%, risk-free interest rates ranging from 3.68% to 5.18%, and an expected term of 1 year. October 3, 2024 On October 3, 2024, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zHiKiRRsse9l">43 shares of Series B Convertible Preferred Stock and committed an additional 4 shares for services/fees for gross consideration of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zYkpoVwqoaR4">43,000. The Company paid $<span id="xdx_90E_eus-gaap--PaymentsOfStockIssuanceCosts_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zAZleTKfomKh">7,860 in selling commissions and legal fees to complete this financing. On October 3, 2024 (the date of receipt of cash proceeds of $39,140), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_904_ecustom--InitialDerivativeLiability_c20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0" title="Initial derivative liability">47,000, $<span id="xdx_902_ecustom--DayOneLossOnDerivative_pp0p0_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zWCm83VdMcrb" title="Day one loss on derivative">16,189 as day one loss on the derivative, $<span id="xdx_90A_eus-gaap--InterestExpenseOther_pp0p0_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zwiBEjAWSrY8">9,400 as interest expense, and $<span id="xdx_909_ecustom--MezzanineDerivativeLiability_c20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0" title="Mezzanine derivative liability">56,400 as Series B Convertible Preferred Stock mezzanine liability, and $<span id="xdx_901_eus-gaap--InterestExpenseDebt_pp0p0_c20241002__20241003__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_zlKZlDxWiey5">39,140 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_907_ecustom--DerivativeLossOnDerivative1_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">4,008 and $<span id="xdx_905_ecustom--DerivativeLossOnDerivative1_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">2,865 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026 and 2025, respectively. In addition, the Company recorded $4,252 and $<span id="xdx_907_eus-gaap--Dividends_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">1,809 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">21,301 and $<span id="xdx_909_eus-gaap--DividendsPayableCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">17,049 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $12,743 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $21,531 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_908_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">50,701 and $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">46,694 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $<span id="xdx_905_ecustom--MezzanineDerivativeLiability_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober2024Member_pp0p0">56,400 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0009, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0012, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 201.59%, risk-free interest rates ranging from 3.68% to 4.16%, and an expected term of 1 year. Series C Convertible Preferred Stock On January 8, 2024, the Board of Directors of the Company had authorized issuance of up to 5,000 shares of preferred stock, $0.001 per share, designated as Series C Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series C Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series C Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series C Convertible Preferred Stock. From and after the issuance date, in addition to the payment of dividends pursuant to Section 3 (a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series C Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights: The Holder shall be entitled to vote on an as-converted basis (subject to the Beneficial Ownership Limitation), together with the holders of Common Stock, with respect to any question upon which the holders of Common Stock have the right to vote, except as may be otherwise provided by applicable law. Except as otherwise expressly provided herein or as required by law, the Holders of Series C Preferred Stock and the holders of Common Stock shall vote together and not as separate classes. Liquidation: Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be paid, in preference and prior to any payment made to the holders of the Junior Securities and any other stock ranking in liquidation junior to the Series C Preferred Stock, an amount per share equal to the Stated Value (such amount is referred to herein as the “Liquidation Preference”). If upon a Liquidation Event, the assets to be distributed among the Holders shall be insufficient to permit payment in full to the Holders of the Liquidation Preference, then the entire assets of the Company shall be distributed ratably among such holders in proportion to the full respective Liquidation Preference to which they are entitled. Conversion: The Holder shall have the right, at any time to convert such shares into Common Stock into that number of shares of common stock (subject to the Beneficial Ownership Limitation (as defined below)) determined by dividing the Stated Value of such share of Series C Preferred Stock by the Optional Conversion Rate (as defined below) (each, and “Optional Conversion”) at a conversion rate of the volume-weighted average price (“VWAP”) for the Company’s common stock for the ten (10) Trading Days immediately preceding the date of such conversion (the “Optional Conversion Rate”). “Trading Days” shall mean a day on which the means the principal markets or exchange on which the common stock is listed or quoted for trading on the date in question is open for business. “Beneficial Ownership Limitation” shall mean 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series C Preferred Stock held by the applicable Holder. No fractional shares of Common Stock shall be issued upon conversion of shares of Series C Preferred Stock. If more than one share of Series C Preferred Stock shall be surrendered, or deemed surrendered, pursuant to subsection (c) above, for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of such Series C Preferred Stock so surrendered. Any fractional share which would otherwise be issuable upon conversion of any shares of Series C Preferred Stock (after aggregating all shares of Series C Preferred Stock held by each holder) shall be rounded to the nearest whole number (with one-half being rounded upward). The Company shall reserve, free from preemptive rights, out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series C Preferred Stock sufficient shares to provide for the conversion of all outstanding shares of Series C Preferred Stock. All shares of Common Stock which may be issued in connection with the conversion provisions set forth herein will, upon issuance by the Company, be validly issued, fully paid and non-assessable, with no personal liability attaching to the ownership thereof, and free from all taxes, liens or charges with respect thereto. All shares of Series C Preferred Stock which have been converted shall no longer be deemed to be outstanding and all rights with respect to such shares including the rights to receive dividends and to vote, shall immediately cease and terminate on the Optional Conversion Date, except only the right of the Holder thereof to receive shares of Common Stock in exchange thereof. The Series C Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging, the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results each reporting period. March 1, 2024 On March 1, 2024, a convertible promissory noteholder and the Company mutually agreed to convert the principal balance of $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z7SSLOeLGHg8" title="Converted principal balance">55,000 and accrued interest of $<span id="xdx_900_ecustom--DebtConversionConvertedInterestAmount1_pp0p0_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_zU52fl65elQ4" title="Accrued interest">13,825 into a total of <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_pdd" title="Debt converted, shares issued">57 shares of Series C Convertible Preferred Stock. The Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90A_ecustom--InitialDerivativeLiability_c20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Initial derivative liability">40,668, $<span id="xdx_90D_eus-gaap--InterestExpenseOther_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_pp0p0" title="Interest expense">425 as contra interest expense, $28,157 as day one gain on the derivative, $<span id="xdx_907_eus-gaap--InterestExpenseDebt_pp0p0_c20240227__20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_z5RJS8ehCsk4">68,825 as a loss recorded on issuance to interest expense, and $<span id="xdx_903_ecustom--MezzanineDerivativeLiability_c20240301__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Mezzanine derivative liability">68,825 as Series C Convertible Preferred Stock mezzanine liability. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_900_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zcQ10yl1HiSg" title="Loss on derivative liability">11,718 and $<span id="xdx_902_ecustom--DerivativeLossOnDerivative1_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Loss on derivative liability">2,565 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026 and 2025, respectively. In addition, the Company recorded $<span id="xdx_90E_eus-gaap--Dividends_c20260101__20260331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Preferred stock dividend expense">4,217 and $<span id="xdx_900_eus-gaap--Dividends_c20250101__20250331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Preferred stock dividend expense">2,024 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90A_eus-gaap--DividendsPayableCurrent_iI_c20260331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zMB8FzAfllTj">30,547 and $<span id="xdx_906_eus-gaap--DividendsPayableCurrent_iI_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_z1Rgvic7gaA9">26,330 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $15,480 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $21,531 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_90E_ecustom--DerivativeLiabilityCurrent_c20260331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Derivative liability payable">50,941 and $<span id="xdx_90F_ecustom--DerivativeLiabilityCurrent_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Derivative liability payable">39,223 as of March 31, 2026 and December 31, 2025, and Series C Convertible Preferred Stock mezzanine liability was $<span id="xdx_90E_ecustom--MezzanineDerivativeLiability_c20260331__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_pp0p0" title="Mezzanine derivative liability"><span id="xdx_901_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20251231__us-gaap--LongtermDebtTypeAxis__custom--NoteBMember__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2024Member_zlX920LxdWe2" title="Mezzanine derivative liability">68,400 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0014, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0014, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 202.70%, risk-free interest rates ranging from 3.68% to 5.09%, and an expected term of 1 year. Series D Convertible Preferred Stock On March 17, 2025, the Board of Directors of the Company had authorized issuance of up to <span id="xdx_905_eus-gaap--TemporaryEquitySharesAuthorized_iI_c20250317__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zVwZkceWSqN3" title="Temporary equity, shares authorized">210 shares of preferred stock, $0.001 par value per share, designated as Series D Convertible Preferred Stock (Note 8). Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series D Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series D Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series D Convertible Preferred Stock. From and after the issuance date, in addition to the payment of dividends pursuant to Section 3 (a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series D Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights: The Holder shall be entitled to vote on an as-converted basis (subject to the Beneficial Ownership Limitation), together with the holders of Common Stock, with respect to any question upon which the holders of Common Stock have the right to vote, except as may be otherwise provided by applicable law. Except as otherwise expressly provided herein or as required by law, the Holders of Series D Preferred Stock and the holders of Common Stock shall vote together and not as separate classes. Liquidation: Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be paid, in preference and prior to any payment made to the holders of the Junior Securities and any other stock ranking in liquidation junior to the Series D Preferred Stock, an amount per share equal to the Stated Value (such amount is referred to herein as the “Liquidation Preference”). If upon a Liquidation Event, the assets to be distributed among the Holders shall be insufficient to permit payment in full to the Holders of the Liquidation Preference, then the entire assets of the Company shall be distributed ratably among such holders in proportion to the full respective Liquidation Preference to which they are entitled. Conversion: The Holder shall have the right, at any time to convert such shares into Common Stock into that number of shares of common stock (subject to the Beneficial Ownership Limitation (as defined below)) determined by dividing the Stated Value of such share of Series D Preferred Stock by the Optional Conversion Rate (as defined below) (each, and “Optional Conversion”) at a conversion rate of the volume-weighted average price (“VWAP”) for the Company’s common stock for the ten (10) Trading Days immediately preceding the date of such conversion (the “Optional Conversion Rate”). “Trading Days” shall mean a day on which the means the principal markets or exchange on which the common stock is listed or quoted for trading on the date in question is open for business. “Beneficial Ownership Limitation” shall mean 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series D Preferred Stock held by the applicable Holder. No fractional shares of Common Stock shall be issued upon conversion of shares of Series D Preferred Stock. If more than one share of Series D Preferred Stock shall be surrendered, or deemed surrendered, pursuant to subsection (c) above, for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of such Series D Preferred Stock so surrendered. Any fractional share which would otherwise be issuable upon conversion of any shares of Series D Preferred Stock (after aggregating all shares of Series D Preferred Stock held by each holder) shall be rounded to the nearest whole number (with one-half being rounded upward). The Company shall reserve, free from preemptive rights, out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series D Preferred Stock sufficient shares to provide for the conversion of all outstanding shares of Series D Preferred Stock. All shares of Common Stock which may be issued in connection with the conversion provisions set forth herein will, upon issuance by the Company, be validly issued, fully paid and non-assessable, with no personal liability attached to ownership thereof, and free from all taxes, liens or charges with respect thereto. All shares of Series D Preferred Stock which have been converted shall no longer be deemed to be outstanding and all rights with respect to such shares including the rights to receive dividends and to vote, shall immediately cease and terminate on the Optional Conversion Date, except only the right of the Holder thereof to receive shares of Common Stock in exchange thereof. The Series D Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging, the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results for each reporting period. March 21, 2025 On March 21, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zsrIhqjgEOJe">60 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zDpyiD1k6XGh">60,000. The Company paid $<span id="xdx_909_eus-gaap--PaymentsOfStockIssuanceCosts_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zKS8t63DT06f">9,200 in selling commissions and legal fees to complete this financing. On March 21, 2025 (the date of receipt of cash proceeds of $50,800), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90F_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_z7oTxk49OZD9">65,024, $<span id="xdx_906_ecustom--DayOneLossOnDerivative_pp0p0_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zjGtj8qaTPJc">14,224 as day one loss on the derivative, $<span id="xdx_907_eus-gaap--InterestExpenseOther_pp0p0_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zuwH2NwseCvf">12,000 as interest expense, and $<span id="xdx_90F_ecustom--MezzanineDerivativeLiability_iI_c20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zt4NKObWZKca" title="Mezzanine derivative liability">72,000 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_905_eus-gaap--InterestExpenseDebt_pp0p0_c20250320__20250321__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zUTYVq8TLTy7">50,800 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $<span id="xdx_90E_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zvoFo3IQwgXc">7,600 and a gain of $<span id="xdx_905_ecustom--DerivativeLossOnDerivative1_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zWl4fGkcCCMk">191 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026 and 2025, respectively. In addition, the Company recorded $<span id="xdx_90A_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_z5w6i2opATL9">4,916 and $<span id="xdx_906_eus-gaap--Dividends_pp0p0_c20250101__20250331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zHHEGWL0Pkwi">237 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90E_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zQYZDivw4rf">19,290 and $<span id="xdx_905_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zOu9ffCLPanl">14,374 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $12,544 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $25,326 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_904_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_z3DyhmP1YwVd">85,570 and $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_zRRfAUeZsk3b">77,970 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_90A_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch2025Member_z3DFS1P9z2x2" title="Mezzanine derivative liability">72,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0008, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.001, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 199.73%, risk-free interest rates ranging from 3.68% to 4.04%, and an expected term of 1 year. April 10, 2025 On April 10, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zwm4JRHr7kGf">45 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_z3yDuenY31Le">45,000. The Company paid $<span id="xdx_90C_eus-gaap--PaymentsOfStockIssuanceCosts_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zXn1wyqKC4Xf">900 in selling commissions and legal fees to complete this financing. On April 10, 2025 (the date of receipt of cash proceeds of $44,100), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_903_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_z6KHE6QxF7ha">57,220, $<span id="xdx_902_ecustom--DayOneLossOnDerivative_pp0p0_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zrUSlSANfhlg">12,220 as day one loss on the derivative, $<span id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zzEk5WPBHzdf">9,000 as interest expense, and $<span id="xdx_90C_ecustom--MezzanineDerivativeLiability_iI_c20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zX062YeRBoLk" title="Mezzanine derivative liability">54,000 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90D_eus-gaap--InterestExpenseDebt_pp0p0_c20250409__20250410__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_z39jezAPOaW">45,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_90C_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zY0xmWI0hb1k">5,700 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_907_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zKXD7VIwbF22">2,632 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90E_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zt5B1YYYh0bc">7,825 and $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zdU5ZXpKbu01">5,193 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $3,120 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $<span id="xdx_902_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zH8ITsXhzUb3">64,177 and $<span id="xdx_900_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zvNzfsn6Rykd">58,477 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_906_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedApril2025Member_zCuHHUxCByf7" title="Mezzanine derivative liability">54,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 199.89%, risk-free interest rates ranging from 3.68% to 3.97%, and an expected term of 1 year. May 14, 2025 - 1 On May 14, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zP0cPmcrF5m5">11 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zgIk08chxobe">11,000. The Company paid $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zIftsfHcORY5">220 in selling commissions and legal fees to complete this financing. On May 10, 2025 (the date of receipt of cash proceeds of $10,780), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_902_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_z2l9FCtVAlp9">13,815, $<span id="xdx_907_ecustom--DayOneLossOnDerivative_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zxWY75X9s34j">2,815 as day one loss on the derivative, $<span id="xdx_90A_eus-gaap--InterestExpenseOther_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zv1yT47tWPt2">2,200 as interest expense, $<span id="xdx_90C_ecustom--MezzanineDerivativeLiability_iI_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zSoaaAlBVpnf" title="Mezzanine derivative liability">13,815 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zdvrPb7naX56">11,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_900_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zr6BJFc6DmLi">1,393 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90E_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zlAHV8PuRPG3">644 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zSRFVrENqvq1">1,755 and $<span id="xdx_902_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zqrGC5TEdlx">1,111 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $753 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $<span id="xdx_90B_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_z45GpdSxFHMk">15,688 and $<span id="xdx_90D_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zUlMrra9HiNb">14,294 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_908_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay2025Member_zR3HRdWa4O9" title="Mezzanine derivative liability">13,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.68% to 4.14%, and an expected term of 1 year. May 14, 2025 - 2 On May 14, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zwHe03TfxPr2">25 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_ztNn02iON73">25,000. The Company paid $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_c20250513__20250514__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zhPzck4drSCi">500 in selling commissions and legal fees to complete this financing. On May 10, 2025 (the date of receipt of cash proceeds of $24,500), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_900_ecustom--InitialDerivativeLiability_iI_pp0p0_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zlwpXLC0zZ4h">31,399, $<span id="xdx_903_ecustom--DayOneLossOnDerivative_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zRKDS8lAhodh">6,399 as day one loss on the derivative, $<span id="xdx_90E_eus-gaap--InterestExpenseOther_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zqdBOU4Qkmta">5,000 as interest expense, $<span id="xdx_902_ecustom--MezzanineDerivativeLiability_iI_c20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zGrehdKKUqFc" title="Mezzanine derivative liability">13,815 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_c20250509__20250510__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zP3XvoAiyMsa">11,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_900_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_z1sS80zdWW3h">3,167 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_900_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zCkl6hmUU4C8">1,463 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_905_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zKPE3Iyloet9">3,989 and $<span id="xdx_908_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zAsweewraZ6h">2,526 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $1,711 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $<span id="xdx_902_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zD9V1wLLIbs">35,654 and $<span id="xdx_909_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zFXleesmpZU3">32,487 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_903_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMay142025Member_zG58w51Sic1j" title="Mezzanine derivative liability">30,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.68% to 4.14%, and an expected term of 1 year. October 30, 2025 On October 30, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z6d1kRjAc9ed">35 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zhCMPGv6UF66">35,000. The Company paid $<span id="xdx_907_eus-gaap--PaymentsOfStockIssuanceCosts_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z6ALggQqYtA">700 in selling commissions and legal fees to complete this financing. On October 30, 2025 (the date of receipt of cash proceeds of $34,300), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90B_ecustom--InitialDerivativeLiability_iI_pp0p0_c20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zX2cmr7Lsy65">28,724, $<span id="xdx_90D_ecustom--DayOneLossOnDerivative_pp0p0_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z6eOk9JE3aa8">6,276 as day one loss on the derivative, $<span id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zNVjZ6Qz6Aua">7,000 as interest expense, $<span id="xdx_90D_ecustom--MezzanineDerivativeLiability_iI_c20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zAwlNNr0DD2g" title="Mezzanine derivative liability">7,000 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20251029__20251030__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zoPpFtrwCH1k">35,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_902_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zOU6UUfiPmY7">4,433 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_901_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zZyGQsNWEuL9">1,927 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_902_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zY4PtuLZnHJ3">3,026 and $<span id="xdx_908_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zFxDlFz7HQt9">1,099 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $2,170 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $<span id="xdx_903_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z7qgwkDOseqc">49,916 and $<span id="xdx_906_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_zmlQX92DHUW2">45,482 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_90C_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedOctober302025Member_z5gA491lkOC7" title="Mezzanine derivative liability">42,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.00048 to $0.0005, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0005 to $0.0008, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 198.95%, risk-free interest rates ranging from 3.48% to 3.70%, and an expected term of 1 year. December 2, 2025 On December 2, 2025, pursuant to the terms of the SPA, GHS purchased <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_z9wei4M78Sw4">34 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zWYaaY3GsItb">34,000. The Company paid $680 in sales commissions and legal fees to complete this financing. On December 2, 2025 (the date of receipt of cash proceeds of $33,320), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90F_ecustom--InitialDerivativeLiability_iI_pp0p0_c20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zvBtmmO5zCHl">36,821, $<span id="xdx_90C_ecustom--DayOneLossOnDerivative_pp0p0_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zKFfHUVkw8gl">2,821 as day one loss on the derivative, $<span id="xdx_908_eus-gaap--InterestExpenseOther_pp0p0_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zlGabcB1PjUa">6,800 as interest expense, $<span id="xdx_903_ecustom--MezzanineDerivativeLiability_iI_c20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zO5IIGEYdwK2" title="Mezzanine derivative liability">6,800 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_906_eus-gaap--InterestExpenseDebt_pp0p0_c20251201__20251202__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zfKQqEOxhmqf">34,000 as a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_90A_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zymHBkNXKMki">4,307 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_901_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zkfvrMUaCRcl">1,836 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_903_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_zjd62PIhjnl6">2,230 and $<span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_z4M0vRxmtTJi">394 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $1,841 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $<span id="xdx_904_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_ztX70asD2xlf">48,490 and $<span id="xdx_900_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20251231__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_ztXtzQpBkLO1">44,183 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_909_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedDecember22025Member_z1jRF2OAJrDe" title="Mezzanine derivative liability">40,800 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.00048 to $0.0006, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0007 to $0.0008, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 198.95%, risk-free interest rates ranging from 3.48% to 3.68%, and an expected term of 1 year. March 12, 2026 On March 12, 2026, pursuant to the terms of the SPA, GHS purchased <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260311__20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zl2Jw0hbJp6" title="Number of shares issued, shares">43 shares of Series D Convertible Preferred Stock for gross consideration of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20260311__20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zrfDyjyjtU15" title="Proceeds from sale of equity">43,000. The Company paid $<span id="xdx_90E_eus-gaap--PaymentsOfStockIssuanceCosts_c20260311__20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zM1rU8yTgVv4" title="Payments of stock issuance costs">2,860 in sales commissions and legal fees to complete this financing. On March 12, 2026 (the date of receipt of cash proceeds of $40,140), the Company valued the fair value of the derivative and recorded an initial derivative liability of $<span id="xdx_90A_ecustom--InitialDerivativeLiability_iI_c20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zPby59WlJOf7" title="Derivative liability payable">57,006, $<span id="xdx_90E_ecustom--DayOneLossOnDerivative_c20260311__20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zNsqMRSope1" title="Derivative loss on derivative">16,866 as day one loss on the derivative, $<span id="xdx_904_eus-gaap--InterestExpenseOther_c20260311__20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zcYPJ9kqioAg" title="Interest expense">8,600 as interest expense, $<span id="xdx_900_ecustom--MezzanineDerivativeLiability_iI_c20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zjX59o9PtVk7" title="Mezzanine derivative liability">8,600 as Series D Convertible Preferred Stock mezzanine liability, and $<span id="xdx_904_eus-gaap--InterestExpenseDebt_c20260311__20260312__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zK5qqWtRNqrd">40,140 as a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $<span id="xdx_90C_ecustom--DerivativeLossOnDerivative1_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zBlF47Rdwng3">4,319 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $<span id="xdx_90D_eus-gaap--Dividends_pp0p0_c20260101__20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zjdKJIMG9zp">357 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $<span id="xdx_90B_eus-gaap--DividendsPayableCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zhjA6tuYGmy3">357 as of March 31, 2026. Derivative liability payable for this transaction totaled $<span id="xdx_906_ecustom--DerivativeLiabilityCurrent_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zznFIW0pXMHd">61,325 as of March 31, 2026, and Series D Convertible Preferred Stock mezzanine liability was $<span id="xdx_903_ecustom--MezzanineDerivativeLiability_iI_pp0p0_c20260331__us-gaap--FinancialInstrumentAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember__us-gaap--TransactionTypeAxis__custom--IssuedMarch122026Member_zNeDxVRgHwe1" title="Mezzanine derivative liability">51,600 as of March 31, 2026. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.00048 to $0.0006, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0008 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 175.68%, risk-free interest rates ranging from 3.66% to 3.68%, and an expected term of 1 year. Series E Preferred Stock On October 30, 2025, the Board of Directors of the Company had authorized issuance of up to 3,000 shares of preferred stock, $0.001 par value per share, designated as Series E Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of 10% per annum, payable quarterly, beginning on the Original Issue Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock, at the Corporation’s discretion. From and after the initial Closing Date, in addition to the payment of dividends, each Holder shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. The Corporation shall pay no dividends on shares of the Common Stock unless it simultaneously complies with the previous sentence. Any dividends that are not paid a Dividend Payment Date shall continue to accrue and shall entail a late fee (“Late Fees”), which must be paid in cash, at the rate of 12% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the Dividend Payment Date through and including the date of actual payment in full. Voting Rights. The Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise pari passu with, the Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise pari passu with, the Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing. Liquidation: Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder. Conversion: Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to certain limitations) determined by dividing the Stated Value of such share of Preferred Stock by Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice. Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the “Conversion Date”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued. Conversion price: The conversion price for the Preferred Stock shall be a fixed price equal to $0.0005. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder’s right to pursue actual damages including, but not limited to, as a result of a Triggering Event pursuant to Section 10 hereof and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. Corporation Redemption: The Corporation shall have the right to redeem, all (but not less than all), shares of the Preferred Stock issued and outstanding at any time after the Original Issue Date, upon three (3) business days’ notice, at a redemption price per Preferred Stock then issued and outstanding (the “Corporation Redemption Price”), equal to the product of (i) the Premium Rate (means 1.10) multiplied by (ii) the sum of (x) the Stated Value, (y) all accrued but unpaid dividends, and (z) all other amount due to the Holder pursuant to this Certificate of Designation and/or any Transaction Document including, but not limited to Late Fees, liquidated damages and the legal fees and expenses of the Holder’s counsel relating to this Certification of Designation, any other Transaction Document and/or the transactions contemplated thereunder and/or hereunder. Notwithstanding the delivery of a Corporation Redemption Notice, a Holder may convert some or all of its shares of Preferred Stock until the date it receives in full Corporation Redemption Price, provided, however, that notwithstanding anything to the contrary provided herein or elsewhere (i) in the event a Holder would be precluded from converting any shares of Preferred Stock, due to the limitation contained in Section 5, the Corporation Redemption Payment Date, for such Holder only, shall automatically be extended by one hundred twenty (120) days (or such shorter period as so provided to the Corporation by the Holder at any time and (ii) if a Mandatory Conversion has occurred prior to the Corporation Redemption Payment Date and for whatever reason including, but not limited to, the Beneficial Ownership Limitation, a Holder still owns Preferred Stock, any such Holder may elect to extend the Corporation Redemption Payment Date as to any or all of such Holder’s Preferred Stock for up to one hundred twenty (120) days following the Corporation Redemption Payment Date to allow such Holder to convert its remaining Preferred Stock into Conversion Shares. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Emmons DEA”) with Clifford L. Emmons, it’s Chief Executive Officer and Director. Pursuant to the Emmons DEA, Mr. Emmons exchanged $<span id="xdx_906_eus-gaap--DebtConversionOriginalDebtAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--TransactionTypeAxis__custom--AccruedCompensationAndUnpaidFeesMember_zhBFAtSh0HP6">387,242 of accrued compensation and unpaid fees owed to him by the Company under various agreements, for <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zdmAb9PDID53">269 shares of the Company’s Series E Convertible Preferred Stock (the “Series E Preferred Stock”). In addition to the issuance of the Company’s Series E Preferred Stock, Mr. Emmons agreed to cancel <span id="xdx_90C_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--EmmonsDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_za7iBKoUJwy4">7,800 shares of Series A Preferred Stock owned by him. The closing of the Emmons DEA occurred on November 5, 2025. The Company recorded dividend expense of $8,237 for the three months ended March 31, 2026, The Company recorded $13,796 and $5,599 as dividend payable to Mr. Emmons as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Mitta DEA”) with Vidhyadhar Mitta, it’s former Director. Pursuant to the Mitta DEA, Mr. Mitta exchanged $<span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember__us-gaap--TransactionTypeAxis__custom--MittaPromissoryNotePayableMember_zvQIoT72O56c">216,156 of principal and accrued and unpaid interest owed to him by the Company under the 12% Secured Convertible Promissory Note issued to Mr. Mitta on August 2, 2019 for <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember__us-gaap--TransactionTypeAxis__custom--MittaPromissoryNotePayableMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBF9UGU3U8r3">180 shares of Series E Preferred Stock. In addition to the issuance of the Series E Preferred Stock, Mr. Mitta agreed to cancel <span id="xdx_903_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--MittaDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zM9J9B8b2nO3">12,000 shares of Series A Preferred Stock owned by him. The closing of the Mitta DEA occurred on November 5, 2025. The Company recorded dividend expense of $5,512 for the three months ended March 31, 2026. The Company recorded $9,233 and $5,559 as dividend payable to Mr. Mitta as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “McNemar DEA”) with Karen McNemar, it’s former Chief Financial Officer. Pursuant to the McNemar DEA, Ms. McNemar exchanged $<span id="xdx_906_eus-gaap--DebtConversionOriginalDebtAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McnemarDEAMember__us-gaap--TransactionTypeAxis__custom--AccruedAndUnpaidFeesMember_zwtx3V9ikVGh">323,269 of accrued and unpaid fees owed to her by the Company under various agreements for <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McnemarDEAMember__us-gaap--TransactionTypeAxis__custom--AccruedAndUnpaidFeesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zeVcsm2llcT1">269 shares of Series E Preferred Stock. In addition to the issuance of the Series E Preferred Stock, Ms. McNemar agreed to cancel <span id="xdx_906_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--McnemarDEAMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdMNjsMq4wc5">6,045 shares of Series A Preferred Stock owned by her. The closing of the McNemar DEA occurred on November 5, 2025. The Company recorded dividend expense of $8,237 for the three months ended March 31, 2026. The Company recorded $13,796 and $5,559 as dividend payable to Ms. McNemar as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Senior Secured DEA”) with Sergey Gogin and Yvsgramorah, LLC, an entity controlled by Mr. Gogin (the “Senior Secured Holders”). Pursuant to the Senior Secured DEA, the Senior Secured Holders exchanged an aggregate of $<span id="xdx_900_eus-gaap--DebtConversionOriginalDebtAmount1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--SeniorSecuredDEAMember__us-gaap--TransactionTypeAxis__custom--GoginSeniorSecuredNotesMember_z8xQOJUV8Rrf">522,195 of principal and accrued and unpaid interest owed to the Senior Secured Holders by the Company under the Senior Secured Convertible Note issued to Mr. Gogin on January 22, 2018 (the “Gogin Note”) and the Senior Secured Convertible Note issued to Yvsgramorah, LLC on March 6, 2019 (the “YVS Note,” together, with the Gogin Note, the “Senior Secured Notes”) for an aggregate of <span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20251029__20251030__us-gaap--DebtConversionByUniqueDescriptionAxis__custom--SeniorSecuredDEAMember__us-gaap--TransactionTypeAxis__custom--GoginSeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zWSXn4iafUPk">489 shares (the “Senior Secured Shares”) of Series E Preferred Stock. The closing of the Senior Secured DEA occurred on November 5, 2025. The Company recorded dividend expense of $14,973 for the three months ended March 31, 2026. The Company recorded $25,079 and $10,106 as dividend payable to Mr. Gogin as of March 31, 2026 and December 31, 2025, respectively. The following table represents the change in the fair value of the derivative liabilities for the three months ended March 31, 2026 and 2025, respectively. <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zawv0K27Szcb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Change in the fair value)"> <tr style="vertical-align: bottom"> <td>Schedule of change in the fair value of the derivative liabilities</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%">Balance at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHXDo2yDhXd2" style="width: 13%; text-align: right" title="Derivative liability, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCb7goMOrlO7" style="width: 13%; text-align: right" title="Derivative liability, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOlAjn4hig01" style="width: 13%; text-align: right" title="Derivative liability, Beginning balance">758,787</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions to derivative liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zNXZPIDSLxve" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeKfMMFmfDIk" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9NpEOEgi6Je" style="text-align: right" title="Additions to derivative liability">64,985</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Gain due to change in the fair value of derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztEUonDwHI6e" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrwp9VD8qzk6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeGainLossOnDerivativeNet_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8bIRNfoSeg1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">(15,724</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJmDk8v7SOc9" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zw53qZZRTJjc" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFnMXzPsG2Zj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">808,048</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2025</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zYB4QnrV7f14" style="text-align: right" title="Derivative liability, Beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8BvJeLMoIvg" style="text-align: right" title="Derivative liability, Beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3293gWODHW2" style="text-align: right" title="Derivative liability, Beginning balance">951,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Additions to derivative liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zK0PvdF7g2vi" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zaDHG4yzBAy6" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zVUm1v9dyK4k" style="text-align: right" title="Additions to derivative liability">57,006</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss due to change in the fair value of derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4QOvctq3NP6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zIqTndf7zcj9" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbN59T2m44Z5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">97,220</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3xZjVNghLk4" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5JKPgM4MwOh" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxKBoepezKD8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">1,105,758</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As a result of issuance of derivative instruments, the Company recorded a derivative liability of $1,105,758 and $951,532 as of March 31, 2026 and December 31, 2025, Series B Convertible Preferred Stock liability of $<span id="xdx_906_ecustom--PreferredStockDerivativeLiability_iI_c20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zRldnl34Pyuc" title="Preferred stock derivative liability"><span id="xdx_909_ecustom--PreferredStockDerivativeLiability_iI_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zGgTZiFKlOIi" title="Preferred stock derivative liability">699,600 as of March 31, 2026 and December 31, 2025, Series C Convertible Preferred Stock liability of $68,400 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock liability of $303,600 and $252,000 as of March 31, 2026 and December 31, 2025, respectively.

10000000000

0.001

10000000

0.001

586385063

100

583

253

1207

952212

5000000

1270000

20000000

14300000

14200000 100000 6000000

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_z9nW5trc4Vfj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Non-vested shares)"> <tr style="vertical-align: bottom"> <td>Schedule of non-vested shares</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">2022 Stock Incentive Plan</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares of Common Stock</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average Exercise Price</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Authorized shares per the 2022 Plan – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLSE9MREVSUycgRVFVSVRZIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z2VKhmxfBYb5" title="Authorized shares">20,000,000 shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%">Balance - December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zlIiv7HQdKCd" style="width: 13%; text-align: right" title="Shares of common stock, Beginning balance">11,200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zjrZoDStgrYe" style="width: 13%; text-align: right" title="Weighted average exercise price, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Awarded</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zW2IHhT88imh" style="text-align: right" title="Shares of common stock, Awarded">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zBVuP52GokGf" style="text-align: right" title="Weighted average exercise price, Awarded">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_iN_di_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zr8xK8OOW4Wa" style="text-align: right" title="Shares of common stock, Issued">(5,100,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z0YevUJfnj99" style="text-align: right" title="Weighted average exercise price, Issued">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zXYntveLSkF9" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zWeER8HVYOj4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance – March 31, 2025 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_ztQRF34Fafwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">6,100,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20250101__20250331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zCSCFDNsO8f8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">0.006146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance - December 31, 2025</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zjX6ZB44vH54" style="text-align: right" title="Shares of common stock, Beginning balance">6,100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zCMU0D9EmlUf" style="text-align: right" title="Weighted average exercise price, Beginning balance">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt">Awarded</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z4OiPYyLRzJl" style="text-align: right" title="Shares of common stock, Awarded">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z2RNDwctVaAf" style="text-align: right" title="Weighted average exercise price, Awarded">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Issued</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_iN_di_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zN9BBaO569U4" style="text-align: right" title="Shares of common stock, Issued">(100,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuedInPeriodWeightedAverageExercisePrice_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_z2UgoNsouBP1" style="text-align: right" title="Weighted average exercise price, Issued">0.006146</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 10pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zSbtIn24m3sd" style="border-bottom: Black 1pt solid; text-align: right" title="Shares of common stock, Forfeited">(6,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zzMiwaoBQMki" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Forfeited">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance – March 31, 2026 – (Unvested)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zdLZTeL3hA0d" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares of common stock, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_d0_c20260101__20260331__us-gaap--PlanNameAxis__custom--StockIncentivePlan2022Member_zUavEUcrksC" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

20000000

11200000

0.006146

5100000

-0

6100000

0.006146

6100000

0.006146

100000

0.006146

6000000

25845

0.001

100

600

0.001

45000

900

103267 58267

39000

45000

6630 2751

18334

2485

197874

179540

84947 78317 84000 84000

85000

1700

106241 21241

17000

85000

8050 3341

21814

3018

237789

215975

103150 95099 102000 102000

51000

1000

4830 2005

25684

1811

114954

89270

61890 57060 61200 61200

51000

1000

65025 14025

10200

51000

4830 2005

10560

1811

93607

83047

61890 57060 61200 61200

136

136000

2720

328422 192422

27200

136000

12880 5345

10158

4829

215658

205500

165040 152159 163200 163200

61000

1220

54072 6928

12200

61000

5777 2398

10267

2166

85266

74999

74025 68248 73200 73200

62000

1240

61679 321

12400

62000

5872 2440

9535

2201

72016

62481

75239 69367

17600

2400

20324 321

4000

24000

20000

1706 678

1957

710

11767

9810

21575 19870 24000 24000

43000

7860

47000 16189

9400

56400

39140

4008 2865

1809

21301

17049

50701 46694 56400

5000

55000

13825

40668

425

68825

68825 11718 2565

4217

2024

30547

26330

50941 39223 68400 68400

210

1200

60000

9200

65024 14224

12000

72000

50800

7600 191

4916

237

19290

14374

85570 77970 72000

45000

900

57220 12220

9000

54000

45000

5700

2632

7825

5193

64177 58477 54000

11000

220

13815 2815

2200

13815

11000

1393

644

1755

1111

15688 14294 13200

25000

500

31399 6399

5000

13815

11000

3167

1463

3989

2526

35654 32487 30000

35000

700

28724 6276

7000

35000

4433

1927

3026

1099

49916 45482 42000

34000

36821 2821

6800

34000

4307

1836

2230

394

48490 44183 40800

43000

2860

57006 16866

8600

40140

4319

357

61325 51600

3000

0.001

1200

387242

269

7800

8237

13796

5599

216156

180

12000

5512

9233

5559

323269

269

6045

8237

13796

5559

522195

489

14973

25079

10106

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zawv0K27Szcb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details - Change in the fair value)"> <tr style="vertical-align: bottom"> <td>Schedule of change in the fair value of the derivative liabilities</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%">Balance at December 31, 2024</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHXDo2yDhXd2" style="width: 13%; text-align: right" title="Derivative liability, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zCb7goMOrlO7" style="width: 13%; text-align: right" title="Derivative liability, Beginning balance">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zOlAjn4hig01" style="width: 13%; text-align: right" title="Derivative liability, Beginning balance">758,787</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions to derivative liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zNXZPIDSLxve" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeKfMMFmfDIk" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9NpEOEgi6Je" style="text-align: right" title="Additions to derivative liability">64,985</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Gain due to change in the fair value of derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_ztEUonDwHI6e" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zrwp9VD8qzk6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--DerivativeGainLossOnDerivativeNet_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z8bIRNfoSeg1" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">(15,724</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2025</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zJmDk8v7SOc9" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zw53qZZRTJjc" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20250101__20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zFnMXzPsG2Zj" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">808,048</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at December 31, 2025</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zYB4QnrV7f14" style="text-align: right" title="Derivative liability, Beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--DerivativeLiabilitiesCurrent_iS_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8BvJeLMoIvg" style="text-align: right" title="Derivative liability, Beginning balance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iS_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3293gWODHW2" style="text-align: right" title="Derivative liability, Beginning balance">951,532</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Additions to derivative liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zK0PvdF7g2vi" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zaDHG4yzBAy6" style="text-align: right" title="Additions to derivative liability">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zVUm1v9dyK4k" style="text-align: right" title="Additions to derivative liability">57,006</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Loss due to change in the fair value of derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4QOvctq3NP6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DerivativeGainLossOnDerivativeNet_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zIqTndf7zcj9" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DerivativeGainLossOnDerivativeNet_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbN59T2m44Z5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in the fair value of derivative liability">97,220</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Balance at March 31, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z3xZjVNghLk4" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilitiesCurrent_iE_d0_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z5JKPgM4MwOh" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iE_c20260101__20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zxKBoepezKD8" style="border-bottom: Black 2.5pt double; text-align: right" title="Derivative liability, Ending balance">1,105,758</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

758787

64985

-15724

808048

951532

57006

97220

1105758

951532

699600 699600 68400 68400 303600 252000

NOTE 8 – SUBSEQUENT EVENTS Management has evaluated all subsequent events through the date of filing. On April 10, 2026, the Board of Directors adopted a resolution to terminate the company’s three equity compensation plans: the 2017 Stock Incentive Plan (the “2017 Plan”), the 2019 Stock Incentive Plan (the “2019 Plan”), and the 2022 Stock Incentive Plan (the “2022 Plan”). Each of the Plans was terminated effective December 31, 2025. On April 16, 2026, the Board of Directors adopted a resolution to approve and authorize an amendment to the Original Certificate of Designation for Series D to increase the total number of authorized shares of Series D Preferred Stock from 210 shares to 500 shares. On April 21, 2026, GHS Investments entered into a financing arrangement and purchased 45 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $43,100, The Company paid sales commissions of $900 and $1,000 in legal fees to complete this sale transaction. On May 6, 2026, the Company entered into an extension to the July 29, 2020 Convertible Promissory Note G issued to GHS Investments in the original principal amount of $75,000.. The maturity date of the Note G was extended from April 29, 2026 to October 31, 2026. In addition, all prior Events of Default (as defined in the Note) were waived by GHS (Note 4). On June 12, 2026, GHS Investments entered into a financing arrangement and purchased 37 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $36,280. The Company paid sales commissions of $720. On July 9, 2026, GHS Investments entered into a financing arrangement and purchased 27 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $26,460. The Company paid sales commissions of $540.

false false false false